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ABSTRACT OF DISSERTATION

TGF-β, WNT, AND FGF
SIGNALING PATHWAYS DURING AXOLOTL TAIL REGENERATION
AND FORELIMB BUD DEVELOPMENT
Tgf-β, Wnt, and Fgf signaling pathways are required for many developmental
processes. Here, I investigated the requirement of these signaling pathways during tail
regeneration and limb development in the Mexican axolotl (Ambystoma mexicanum).
Using small chemical inhibitors during tail regeneration, I found that the Tgf-β
signaling pathway was required from 0-24 and 48-72 hours post tail amputation (hpa),
the Wnt signaling pathway was required from 0-120 hpa, and the Fgf signaling
pathway was required from 0-12hpa. Tgf-β1 was upregulated after amputation and
thus may mediate Tgf-β signaling pathway during tail regeneration. Both Smadmediated and non-Smad mediated Tgf-β signaling were activated as early as 1hpa.
Smad-mediated Tgf-β signaling via activated pSmad2 and pSmad3, and via
phosphorylated Erk and Akt. Two different Tgf-β signaling pathway inhibitors,
SB505124 and Naringenin, differentially regulated pSmad2, pSmad3, p-Erk, and pAkt, while SB505124 and Naringenin both inhibited tail regeneration; only SB505124
reduced cell proliferation. Wnt/β-Catenin signaling was increased and was enhanced
by Wnt-C59. Disruption of the Wnt signaling pathway directly or indirectly activated
Erk and Akt signaling. Disruption of the Fgf signaling pathway decreased p-Erk and
increased p-Akt. All three signaling pathways affected cell proliferation and mitosis
during tail regeneration.
The Wnt pathway inhibitor Wnt-C59 prevented forelimb bud outgrowth. The critical
window for Wnt signaling regulating forelimb bud outgrowth was approximately
developmental stage 40-42. Wnt signaling ligand Wnt3a and tight junction protein
Zo-1 were expressed in the epidermis of the forelimb bud and both were downregulated by Wnt-C59. Moreover, both Wnt and Fgf signaling pathways affected cell
proliferation and mitosis of mesodermal cells during forelimb bud outgrowth.
Overall, my results show that Tgf-β, Wnt, and Fgf signaling pathways are required for
axolotl tail regeneration. All three pathways affect Erk and Akt signaling and guide
cell proliferation and mitosis. The Wnt signaling pathway is required for forelimb bud
outgrowth, and it appears to regulate expression of Wnt3a and Zo1, and control cell

proliferation and mitosis of mesodermal cells underlying the forelimb epidermis.
These data enrich understanding of signaling network dynamics that underlie tissue
regeneration and vertebrate limb development.
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CHAPTER 1: INTRODUCTION
Qingchao Qiu1
1

Department of Neuroscience, University of Kentucky, Lexington, Kentucky
KEYWORDS: Tgf-β, Wnt, Fgf, regeneration, limb development

1.1 Preface
How organisms regenerate body parts is not entirely understood. Using genetic and
pharmaceutical methods, several signaling pathways have been shown to play
essential roles during tissue regeneration. In this chapter, I review the Transforming
growth factor beta (Tgf-β), Wingless/Integrated (Wnt), and Fibroblast growth factor
(Fgf) signaling pathways in regulating wound epithelium formation, blastema
formation, and cell proliferation during tissue regeneration. I also review Wnt and Fgf
signaling pathways during limb development. Understanding signaling pathway
dynamics during tissue regeneration and embryonic development may shed light on
mechanisms of tissue regeneration and suggest therapeutic strategies to enhance
regenerative ability in mammals.

1.2 Tissue regeneration
1.2.1 Cellular basis of tissue regeneration in animals
In recent years, cell lineage tracing and transplantation studies have identified
progenitor cell populations that orchestrate tissue regeneration responses in many
classical model organisms (Tanaka and Reddien 2011; Cary et al. 2019; Fink,
Andersson-Rolf, and Koo 2015). Planaria regenerate an entire body from a tiny body
fragment with pluripotent stem cells called clonogenic neoblasts (Wagner, Wang, and
Reddien 2011; Scimone et al. 2014). A small body fragment of Hydra regenerates an
individual similar to the original through ectodermal and endodermal epithelial stem
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cells and interstitial stem cells (Bosch 2007; Govindasamy, Murthy, and Ghanekar
2014). Axolotl appendages and Xenopus tails harbor tissue and germ layer restricted
progenitors that are recruited to form a regeneration blastema (Tanaka and Reddien
2011; Bryant, Endo, and Gardiner 2002; Gargioli and Slack 2004; Mochii, Taniguchi,
and Shikata 2007). For example, axolotl Schwann cells regenerate from Schwann
cells only, progenitor cells in muscle regenerate muscle, and progenitor cells in
cartilage regenerates cartilage. In contrast, dermal cells regenerate dermis, connective
tissue, and cartilage in a germ layer-specific manner (Kragl et al. 2009). These
lineage tracing studies provide valuable information for understanding the cellular
basis of tissue regeneration. How signaling pathways control these cellular behaviors
during tissue regeneration is poorly understood.

1.2.2 Signaling pathways and tissue regeneration in vertebrates
Salamanders regenerate many body parts such as limb, tail, lens, heart, spinal cord,
and brain (Sugiura et al. 2016; Nacu et al. 2016; Franklin, Voss, and Osborn 2017;
Suetsugu-Maki et al. 2012; Nakamura et al. 2016; Tazaki, Tanaka, and Fei 2017;
Amamoto et al. 2016). Upon limb amputation, epithelial cells migrate to the exposed
wound surface and form a wound epithelium (Carlson, Bryant, and Gardiner 1998;
Nye et al. 2003; Satoh et al. 2008). This wound epithelium thickens and matures into
a signaling center that is called the Apical Epithelial Cap (AEC) (Christensen and
Tassava 2000). Interactions between the AEC and underlying cells in the stump are
considered to activate and support the proliferating undifferentiated blastemal cells, of
which the majority are thought to be connective tissue cells (Satoh, Bryant, and
Gardiner 2012). Multiple signaling pathways, including Tgf-β, Wnt, and Fgf signaling
pathways are known to be deployed during tissue regeneration to regulate cellular and
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developmental processes associated with tissue repair and the formation of new
tissues (Ho and Whitman 2008; Singh et al. 2018; Peiris et al. 2016; Herman et al.
2018). Detailing where and when signaling pathways are deployed during
regeneration is essential to understanding how regeneration programs are regulated.

1.2.3 The axolotl embryo tail regeneration model is an excellent animal model to use
small molecule inhibitors to perturb and study signaling pathways associated with
tissue regeneration.
It is through the perturbation of signaling pathways that we learn about their necessity
and requirement for regeneration. The axolotl assay uses hatching stage 42 embryos
(Ponomareva et al. 2015) that are capable of regenerating amputated distal tail tips in
7 days. Although axolotl limb regeneration has been studied most, it is not well suited
for signaling pathway analysis. First, it takes several months for a fully developed
limb to form. Second, the size of an axolotl with fully developed limbs is too large for
the whole body, chemical treatment. Third, it takes about 40-50 days for a juvenile
axolotl to regenerate a limb and even longer time for post-metamorphic adult axolotls
to regenerate their limbs (Young, Bailey, and Dalley 1983). In contrast, the axolotl
embryo tail regeneration model has several advantages for studying cell signaling
pathways. First, hatching stage embryos have well-developed tails in less than 30
days. Second, the size of the hatching stage embryo is about 1cm long, allowing them
to be reared individually in 12-well, microtiter plates with small volumes of chemical
solution. Third, a hatching stage embryo is capable of regenerating 2mm of the distal
amputated tail in 7 days. Fourth, the endpoint of the experiment is an easy to score,
morphological difference in body length, fin width, and fin shape. Fifth, chemicals
can be directly dissolved in embryo rearing water to study molecular events during
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tail regeneration. Lastly, axolotl embryo development is slow, allowing higher
temporal resolution of molecular and cellular events that overlap in rapidly growing
model organisms like Danio rerio (zebrafish) and Xenopus laevis (Xenopus). Axolotl
embryos are also good to use for limb development studies, which will be discussed
later.
1.3 Tgf-β signaling pathway and tissue regeneration
1.3.1 Tgf-β signaling pathway
The Tgf-β signaling pathway has been well characterized in many species and cell
culture studies. The Tgf-β signaling pathway is mediated by multiple ligands and
receptors (Wrana et al. 1992; Attisano et al. 1993; Zhang et al. 1996). In general, Tgfβ, Activin or Nodal bind with Tgf-β type II receptors on the cell membrane, causing
the recruitment and transphosphorylation of Tgf-β type I receptors, Alk5, Alk4, and
Alk7 (DaCosta Byfield et al. 2004). Activated Tgf-β type I receptors phosphorylate
Smad2 and Smad3, which then interact with Smad4, a co-Smad that mediates
translocation into the nucleus. The Smad2/Smad3/Smad4 complex binds specific
DNA motifs to regulate transcription through various co-activator or co-repressor
proteins (Derynck and Zhang 2003). Therefore, phosphorylated Smad2 and Smad3
are essential transcription factors in Smad-mediated Tgf-β signaling pathways. On the
other hand, non-Smad-mediated Tgf-β signaling pathway can be activated by
phosphorylating extracellular-signal-regulated kinase (Erk) and Akt signaling
pathways (Zhang 2009). Erk and Akt signaling are central cassettes of the mitogenactivated protein kinase (Mapk) signaling pathway that regulates wound contraction
and cell proliferation during Xenopus embryonic wound healing (Shaul and Seger
2007; Li et al. 2013; Li et al. 2016). Tgf-β signaling also rapidly activates Akt
signaling. Akt signaling is essential in regulating neoblast behavior and mediates

6

injury-mediated cell death during planarian tissue regeneration (Peiris et al. 2016).
Down-regulation of Akt function by RNAi increased cell death throughout the body
of a planarian (Peiris et al. 2016).

1.3.2 Tgf-β signaling pathway inhibitor SB505124
SB505124 is a selective and specific inhibitor for Tgf-β Type I receptors Alk4, Alk5,
and Alk7, but not Alk1, Alk2, Alk3, and Alk6 (DaCosta Byfield et al. 2004). Treating
cells with Tgf-β1 or Activin leads to phosphorylation of Alk5 and Alk4, respectively,
which activate their downstream substrates Smad2 and Smad3 (DaCosta Byfield et al.
2004), while BMP treated cells result in phosphorylation of Alk1, Alk2, Alk3, and
Alk6, which then enable phosphorylation of Smad1, 5, and 8 (Heldin, Miyazono, and
ten Dijke 1997). Alk7 mediates signaling by Nodal, another member of the Tgf-β
superfamily. SB505124 has been developed initially as a competitive inhibitor of
Alk5 by binding its ATP binding site, but it also inhibits Alk4 and Alk7. It is more
potent and less toxic than a related Alk5 inhibitor SB431542 (DaCosta Byfield et al.
2004). Therefore, SB505124 provides a valuable small molecule for perturbing the
Tgf-β signaling pathway. In chapter 2, I used SB505124 to disrupt the Tgf-β signaling
pathway during axolotl tail regeneration.

1.3.3 Tgf-β signaling pathway inhibitor Naringenin
Naringenin has been described as a pSmad3 inhibitor. It is the most abundant natural
component from grapefruit and related citrus (Guengerich and Kim 1990).
Interestingly, it was not shown to inhibit axolotl limb regeneration (Denis et al. 2016).
In chapter 2, I used Naringenin to evaluate its effects on inhibiting phosphorylation of
Smad3 during axolotl tail regeneration.
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1.3.4 Tgf-β signaling during tissue regeneration
The full nucleotide sequence of Tgf-β1 has been cloned, and three Tgf-β receptors,
Tgf-β receptor I, II, and III have been identified in axolotl tissues. Tgf-β1 expression
is strongly upregulated at 6hpa and maintained throughout axolotl limb regeneration
(Denis et al. 2016; Levesque et al. 2007). Tgf-β2 is upregulated at 4hpa and Tgf-β5 is
up-regulated at 2hpa during Xenopus tail regeneration (Ho and Whitman 2008).
During lizard tail regeneration, activin-βA is strongly upregulated during the early
stages of regeneration (Gilbert, Vickaryous, and Viloria-Petit 2013). Morpholino
knockdown of activin-βA or its receptor Alk4 impairs zebrafish fin regeneration by
affecting the migration of wound epithelial cells and formation of the blastema
(Jazwinska, Badakov, and Keating 2007). The Tgf-β signaling pathway is also
implicated in early wound healing processes during Xenopus tail regeneration (Ho
and Whitman 2008). Both Tgf-β/Smad and Tgf-β/p38/Jnk pathways play roles in
wound epithelial formation by affecting wound closure, which is associated with
changes in the expression of epithelium mesenchymal transition markers Slug, Zeb2,
Twist3, Vimentin, and N-cadherin (Sader et al. 2019). Tgf-β signaling also plays an
important role in regulating the cell proliferation response during tissue regeneration.
SB431542 inhibition of Tgf-β signaling pathway for seven days and 14 days
irreversibly prevented limb regeneration by downregulating blastemal cell
proliferation during axolotl limb regeneration (Levesque et al. 2007). Similarly,
chemical inhibition of Tgf-β in the Xenopus tadpole tail model blocked blastema cell
proliferation (Ho and Whitman, 2008).
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The Tgf-β signaling pathway regulates the transcription, translation, and posttranslation modification of target genes through phosphorylation of Smad2 and
Smad3 (Christensen and Tassava 2000; Chablais and Jazwinska 2012; Denis et al.
2016). P-Smad2, but not p-Smad3 is required in axolotl limb regeneration (Denis et
al. 2016). Activation of Smad3 via Tgf-β/activin signaling pathway is essential for the
formation of a transient scar that is permissive for zebrafish heart regeneration
(Chablais and Jazwinska 2012). P-Smad2 is also expressed at 6 hpa in the Xenopus
laevis tadpole tail and SB431542 inhibition of Tgf-β signaling reduced p-Smad2
expression during Xenopus tail regeneration (Sato, Umesono, and Mochii 2018). A
Tgf-β signaling pathway target gene, fibronectin, is strongly expressed in the basal
layer of the AEC (Christensen and Tassava 2000). Inhibition of the Tgf-β signaling
pathway by SB431542 reduced fibronectin expression and blocked blastema
formation during axolotl limb regeneration (Levesque et al. 2007). A proteomic study
using regenerating axolotl limbs presented a model wherein Tgf-β and fibronectin
activate transcription factors Sp1 and c-Myc, respectively, which potentially play
essential roles during axolotl limb regeneration (Jhamb et al. 2011). The Tgf-β
signaling pathway also activates non-Smad mediated signaling via Erk during
Xenopus tadpoles tail regeneration (Ho and Whitman 2008). Thus, in the axolotl limb
and Xenopus tail regeneration models, Tgf-β signals through both Smad-mediated and
non-Smad mediated signaling pathways. However, it is unknown if Smad-mediated
and non-Smad-mediated Tgf-β signaling regulates essential processes during axolotl
tail regeneration. In chapter 2, I present data showing that Smad-mediated and nonSmad mediated signaling regulate cell mitosis and cell proliferation during axolotl tail
regeneration.

9

1.4 Wnt signaling pathway and tissue regeneration
1.4.1 Wnt signaling pathway
The central logic of the Wnt signaling pathway has emerged from three decades of
study. Wnt proteins are conserved, secreted signaling molecules that play a myriad of
biological roles in controlling developmental processes (Willert and Nusse 2012).
Multiple cytoplasmic, nuclear, and extracellular components modulate Wnt signaling
(Nusse 2005). There are 19 Wnt genes found in human and the mouse. The Xenopus
tropicalis genome contains orthologues of all 19 mammalian Wnt genes (Yang 2003).
Wnt protein binds the N-terminal extracellular cysteine-rich domain of a seven
transmembrane molecule Frizzled (Fz) family receptor, alongside interactions with
co-receptors including lipoprotein receptor-related (Lrp)5/6, Ror2 and receptor
tyrosine kinase (Rtk) (Komiya and Habas 2008). Upon activation of the receptor, the
Fz directly binds to Dsh which has three conserved protein domains: a central PDZ
domain, an amino-terminal DIX domain, and a carboxy-terminal DEP domain (Wong
et al. 2003). It is through the three domains of Dsh that canonical Wnt/β-Catenin, and
non-canonical planar cell and calcium Wnt signaling, are accomplished (Habas and
Dawid 2005).

In the absence of Wnt ligand, cytoplasmic β-Catenin is degraded continuously by the
action of a destruction complex composed of scaffolding protein Axin, the
adenomatous polyposis coli gene product Apc, glycogen synthase kinase 3 (Gsk3),
protein phosphatase 2A (Pp2A), and casein kinase 1. Upon activation of Dsh through
phosphorylation, DIX and PDZ domains of Dsh inhibit activity of Gsk3 in the
destruction complex and lower the activity of the destruction complex (MacDonald,
Tamai et al. 2009, Minde, Anvarian et al. 2011). The consequence of the low the
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activity of destruction complex leads to accumulation and stabilization of the βCatenin protein. The β-Catenin translocates into the nucleus and acts as a coactivator
of Tcf/Lef family transcription factors (Minde et al. 2013; Minde et al. 2011;
MacDonald, Tamai, and He 2009).

The non-canonical Wnt pathways are independent of β-Catenin. The noncanonical
Wnt/PCP pathways use the PDZ and DIX domains of Dsh binding to Dishevelledassociated activator of morphogeneis1(DAAM1) and activate the G-protein Rho
(MacDonald, Tamai, and He 2009). Rho activates Rho-associated kinase (Rock) and
regulates the cytoskeleton (Amano, Nakayama, and Kaibuchi 2010). Dsh also binds to
Rac1 to mediate profilin binding to actin, which activates Jnk and affects actin
polymerization (Spiering and Hodgson 2011).

In the noncanonical Wnt/calcium pathways, Fz recruits Dsh through PDZ and DEP
domains and directly interacts with a trimeric G-protein (MacDonald and He 2012).
This co-stimulation of Dsh and G-protein leads to activation of either PLC, which
promotes calcium release, or cGMP-specific PDE, which inhibits calcium release
from the ER (Thakur et al. 2016). The Wnt/Calcium signaling pathway regulates
many processes during development, including convergent extension movement,
dorsoventral polarity, and organ formation (Lin et al. 2010; Freisinger, Fisher, and
Slusarski 2010).

1.4.2 Porcupine inhibitor Wnt-C59
Wnt proteins are modified by palmitoylation. Palmitoylation is a hydrophobic
modification of a conserved cysteine reside that affects Wnt protein transport and
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distribution (Kurayoshi et al. 2007; Zhai, Chaturvedi, and Cumberledge 2004). Wnt
proteins treated with enzyme acyl protein thioesterase are not hydrophobic or active,
thus establishing that palmitate is essential for Wnt signaling (Nusse 2005). Studies in
Drosophila and vertebrates have shown that Wnt palmitoylation is controlled by a
membrane-bound O-acyl transferase called Porcupine, which is critical for generating
Wnt secretion and gradients. Lack of Porcupine activity produces a phenotype similar
to those of the Wg mutant in Drosophila (Medina, Taylor, and Donovan 1997).
During chick neural tube development, Porcupine-mediated lipid modification
reduces the activity of Wnt1 and Wnt3a (Galli et al. 2007). These studies show that by
blocking Porcupine activity, Wnt secretion and activity is decreased. A Porcupine
inhibitor, Wnt-C59, was used to block Wnt signaling during tail regeneration in
chapter 3 and axolotl forelimb bud outgrowth in chapter 5. My results show that Wnt
signaling is required for tail regeneration and limb development.

1.4.3 Wnt signaling pathway during tissue regeneration
The Wnt signaling pathway controls many tissue regeneration processes (Kawakami
et al. 2006; Ghosh et al. 2008; Shimokawa et al. 2013; Hamilton, Sun, and Henry
2016; Yokoyama et al. 2011; Sugiura et al. 2009; Lin and Slack 2008). In nonvertebrates, Wnt/β-Catenin signaling pathway defines anteroposterior identity during
regeneration. Upon depletion of β-Catenin, an amputated planarian tail regenerates
into a head instead of a tail, and this leads to the generation of multiple heads
suggesting that β-Catenin maintains anteroposterior identity during homeostasis and
regeneration in planarians (Petersen and Reddien 2008; Gurley, Rink, and Sanchez
Alvarado 2008). In Hydra, Wnt3a is expressed at the tip of the head of an intact
animal and is rapidly re-expressed in head regenerate tips after amputation through
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triggering an autocatalytic feedback loop (Hobmayer et al. 2000; Nakamura et al.
2011). Knock down of Sp5, a transcriptional repressor of Wnt3, yields a robust multiheaded phenotype after head amputation in Hydra (Nakamura et al. 2011). Beane et,
al (2012) used RNAi to target components of the PCP pathway in planarian to
dysregulate visual neuronal cell growth. Their findings suggest that PCP signaling is
required to halt neuronal growth after the completion of tissue patterning during
planarian regeneration. Both canonical and non-canonical Wnt signaling pathways are
also involved in vertebrate tissue regeneration. Wnt-7a is expressed throughout
axolotl limb regeneration (Shimokawa et al. 2013). Inhibiting the Wnt/β-Catenin
signaling pathway prevents limb regeneration in axolotl larvae and fin regeneration in
zebrafish by inducing alterations in the formation of the AEC that associated with the
spatiotemporal regulation of p63 (Kawakami et al. 2006). β-Catenin overexpression
induces limb regeneration in non-regeneration competent pre-apical ectodermal ridge
(AER) chick embryos; in contrast, overexpression of p63 does not induce
regeneration (Kawakami et al. 2006). The non-canonical Wnt signaling pathway is
also crucial to regulate tissue regeneration. Overexpression of Wn5a during Xenopus
tail regeneration induces ectopic larval tails at the injury site, presumably by altering
JNK signaling (Sugiura et al. 2009). Interestingly, not only does blocking Wnt protein
secretion and activity by Wnt-C59 prevent axolotl tail regeneration, but also
activation of Wnt signaling by Wnt agonists differentially impairs axolotl limb
regeneration, and prevents Xenopus cornea-lens regeneration and newt Wolffian-lens
regeneration (Wischin et al. 2017; Hamilton, Sun, and Henry 2016). Suppression of
Wnt/β-Catenin signaling is required for Xenopus limb regeneration and cornea-lens
regeneration (Yokoyama et al. 2011; Hamilton, Sun, and Henry 2016). These findings
suggest that Wnt/β-Catenin signaling is temporally regulated during regeneration.
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Wnt ligands have opposing effects on β-Catenin and tissue regeneration (StoickCooper et al. 2007). Generally, Wnt3a stabilizes β-Catenin and mediates canonical
Wnt/β-Catenin signaling (Hino et al. 2003). Noncanonical Wnt signaling pathway is
independent of β-Catenin and is mediated by Wnt5a. However, it is reported that
Wnt5a promotes Gsk-3-independent β-Catenin degradation and inhibits the canonical
Wnt pathway (Topol et al. 2003). Therefore, Wnt5a is regarded as a link between
canonical and non-canonical Wnt signaling. Ponomareva et al (2015) used both
inhibitors and agonists to disrupt Wnt signaling pathway during axolotl tail
regeneration. They found that Wnt antagonist IWR-1-end, Porcupine inhibitor WntC59, and Wnt agonist II SKL blocked axolotl tail regeneration (Ponomareva et al.
2015). Transcriptional data showed that Wnt-C59 treatment affected transcription of
genes associated with Wnt, Fgf, Tgf-β, Hox, Egf, Myc, Notch, Ngf, Ras/Mapk, p53,
and retinoic acid (RA) pathways. Thus, Wnt signaling, via the transcriptional
regulation of key target genes, may integrate multiple pathways during tissue
regeneration (Ponomareva et al. 2015). Most differentially expressed genes were
discovered between Wnt-C59 treated and control embryos after 24 hours post tail
amputation (hpa) (Ponomareva et al. 2015). I used the same tail regeneration model
and Porcupine inhibitor Wnt-C59 to more finely investigate the requirement of Wnt
signaling during axolotl tail regeneration in Chapter 3.

1.5 Fgf signaling pathway and tissue regeneration
1.5.1 Fgf signaling pathway and Fgfr inhibitor BGJ398
Fgf signaling is essential for cell proliferation, differentiation, migration, mitogenesis,
angiogenesis, and embryogenesis (Ornitz and Marie 2015). In vertebrates, there are 22
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Fgf genes grouped into seven subfamilies and four Fgf receptors (Fgfrs) in vertebrates
(Dorey and Amaya 2010). Fgf signaling is initiated by the binding of Fgf ligands to
Fgfrs. A ligand-dependent dimerization event yields a complex consisting of two
Fgfs, two heparin sulfate chains, and two Fgfrs (Plotnikov et al. 1999). Each Fgf
ligand binds to two Fgf receptors contacted with each other via the D2 domain and
trans-phosphorylates each Fgf receptor monomer (Schlessinger 2000). Upon the
binding of Fgf ligands and its receptors, the tyrosine residues on the docking protein
Frs2-α is phosphorylated (Hadari et al. 2001). The Ras/Map kinase and PI3/Akt
pathways act downstream of Fgf signaling (Armstrong et al. 2006). The Ras/Map
kinase pathway is associated with cellular proliferation and differentiation (Shapiro
2002). Map kinase effectors include extracellular signal-related kinase (Erk), c-Jun Nterminal kinase (Jnk), and p38 mitogen-activated kinase (Cargnello and Roux 2011).
The PI3/Akt pathway is implicated in cell survival and cell fate determination during
mammal embryonic development (Yu and Cui 2016). BGJ398 is a selective and
potent Fgfr inhibitor of Fgfr1/2/3 (Guagnano et al. 2011). I used BGJ398 in chapter 4
to block Fgf signaling during axolotl tail regeneration. I also used BGJ398 in chapter
5 to assess the requirement of Fgf signaling during axolotl forelimb development.

1.5.2 Fgf signaling pathway during tissue regeneration
Fgfs have been studied as neurotrophic and mitogenic factors during tissue
regeneration for more than 40 years (Gospodarowicz 1976). Fgf1 signaling is
associated with AEC formation and activation of underlying progenitor cells in the
axolotl limb that have the potential to differentiate into different tissues (Dungan et al.
2002). Fgf8 is expressed in the basal layer of the AEC, and Fgf8 and Fgf10 are
upregulated in cells underlying the AEC during axolotl limb regeneration.
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Denervation prevents Fgf8 and Fgf10 upregulation during axolotl limb regeneration,
suggesting that Fgf signaling is nerve-dependent (Kolodziej et al. 2001; Han, An, and
Kim 2001). Indeed, Fgf2 and Fgf8 are expressed in nerve tissue and the AEC during
axolotl limb regeneration (Mullen et al. 1996). Fgf2 and Fgf8 act as trophic factors to
maintain Prrx-1 expression in progenitor cells and promote blastema formation during
axolotl limb regeneration (Mullen et al. 1996; Satoh et al. 2011). Fgf2 and Fgf8,
together with growth and differentiation factor-5 (Gdf5), are sufficient to substitute
for nerve induction of limb regeneration (Makanae et al. 2013). Fgf2 and Fgf8 induce
bump formation during limb regeneration, and Fgf2+Fgf8+Bmp7 or Bmp2 induce
limb formation during skin wound healing using the accessory axolotl limb model
(Makanae, Mitogawa, and Satoh 2014). Fgf2+Fgf8+Bmp7 also induce tail
regeneration in the axolotl (Makanae, Mitogawa, and Satoh 2016). Ectopic Fgf8 and
endogenous Hh signaling pathway are sufficient to induce posterior axolotl limb
regeneration (Nacu et al. 2016). The requirement for Fgf has also been shown to be
relatively late for outgrowth of tail tissue in Xenopus by using Fgfr antagonist
SU5402 and heat shock inducible XFD. The Fgf signaling pathway is also required
for Xenopus lens regeneration (Lin and Slack 2008; Fukui and Henry 2011). In the
zebrafish “devoid of blastema” mutant, a blastema fails to form during fin
regeneration. It was discovered that this mutant is caused by a Fgf20a null allele, thus
establishing Fgf signaling is essential for blastema formation during zebrafish fin
regeneration (Whitehead et al. 2005). Fgf3 and Fgf10a are responsible for the later
stage of blastemal formation in zebrafish fin regeneration (Shibata et al. 2016). Taken
together, Fgf signaling is associated with neurotrophic factors that sustain progenitor
cell proliferation and blastema formation during tissue regeneration.
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1.6 Interactions of signaling pathways during tissue regeneration
In response to artificial amputation or natural injury, animals activate a complex
series of responses which lead to local and systemic changes in molecules that
function in signaling pathways. Studies have shown that TGF-β, Wnt, and Fgf
signaling pathways are activated during tissue regeneration in many different species.
Signaling pathways comprise complex networks that are regulated through positive
and negative regulatory interactions. Here I provide a brief overview of regulatory
interactions among the TGF-β, Wnt, and Fgf pathways.

Tgf-β, Wnt, and Fgf signaling pathways interact at multiple levels. First, these
signaling pathways reciprocally regulate ligand production during development and
regeneration. For example, Wnt signal pathway inhibitor Wnt-C59 decreases
transcription of Tgf-β1 and Fgf9 during axolotl tail regeneration (Ponomareva et al.
2015). Second, nucleus components of different signaling pathways can form
complexes to regulate shared target genes in a synergistic manner, at least in cell
culture studies (Edlund et al. 2005). Third, cytoplasmic components of different
pathways interact to repress or activate specific mechanisms of signal transduction.
For example, the interaction of Bmp/TGF-b signaling component Smad7, and Wnt
signaling component Axin stabilizes β-catenin, forming a complex with E-cadherin to
modulate cell-cell adhesion (Tang et al. 2008).

Because components of signaling pathways interact, it is essential to determine their
organization in time and space; in other words, it is essential to determine if pathways
function hierarchically or in parallel, which has proven difficult in tissue regeneration
studies. For example, inhibiting Wnt/β-Catenin signaling pathway abolishes Fgf8

17

expression in the blastema during Xenopus limb regeneration (Lin and Slack 2008).
Moreover, Fgf signaling acts downstream of Wnt/β-Catenin in both Xenopus limb
regeneration and zebrafish fin regeneration (Poss et al. 2000; Yokoyama et al. 2007;
Stoick-Cooper et al. 2007). However, Fgfr antagonist SU-5402 decreases Wnt3a and
Wnt5a expression during Xenopus tail regeneration, suggesting that feedback
regulation of Wnt expression by Fgf signaling is not a simple upstream-downstream
relationship (Lin and Slack 2008). Although studies have independently established
the requirement of TGF-β, Wnt, and Fgf signaling pathways in different tissue
regeneration models, there is a need to examine all three pathways within the context
of a single model. Such data are fundamental to tackling the more difficult question of
how signaling pathways interact to regulate tissue regeneration processes.

1.7 Wnt and Fgf signaling pathways during limb development
Signaling pathway interactions have received greater study in models of limb
development. During chicken limb development, limb bud outgrowth depends on
signals from the apical ectodermal ridge (AER) (Hamburger and Hamilton 1992).
Fibroblast growth factors expressed in the AER are sufficient and necessary for AER
function in proximal-distal limb outgrowth and patterning (Niswander and Martin
1993; Saunders 1998; Mariani, Ahn, and Martin 2008). Absence of Fgf4 and Fgf8
leads to failure of limb development. Wnt signals, including Wnt7a expression in nonAER limb ectoderm, determines dorsal limb cell identity and thus dorsal-ventral axis
regulation (Riddle et al. 1995). Therefore, Fgf and Wnt signaling pathways crucially
determine limb axial polarity (Tickle 2015). A regulatory loop of multiple Wnt
(Wnt3a, Wnt2b, and Wnt8c) and Fgf (Fgf8 and Fgf10) genes controls limb initiation
and AER induction (Kawakami et al. 2001). Wnt3a is the earliest known AER marker
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during limb development, it signals through the canonical β-Catenin pathway and
mediates the induction of Fgf8 in the limb ectoderm by Fgf10 during AER formation
(Kengaku et al. 1998; Kawakami et al. 2001). Moreover, gradients of Wnt5a establish
planar cell polarity in chondrocytes along the P-D axis by regulating Vangl2
phosphorylation during mice limb development (Gao and Yang 2013; Qian et al.
2007).

During axolotl limb development, a visible AER does not form. Fgf8 is initially
expressed in the epidermis in the prospective forelimb region of the limb bud at
developmental stage 42. Fgf8 is expressed in both epidermis and mesenchyme at one
day after stage 42, then Fgf8 is expressed mainly in the mesenchyme of the bud until
digits form approximately 14 days later (Han, An, and Kim 2001). As in other
vertebrates, sonic hedgehog (Shh) is expressed in posterior regions of the developing
limb bud (Torok et al. 1999; Nacu et al. 2016). Wnt5a is expressed mainly in the
distal apical ectoderm at stage 36 of the forelimb and hindlimb bud. Wnt5b is
observed in the mesenchyme of the forelimb and hindlimb bud at developmental stage
36 (Ghosh et al. 2008). Wnt7a is expressed diffusely in the distal part of the limb
throughout limb development (Shimokawa et al. 2013). Most studies of axolotl limb
development to date have been descriptive and have not used functional approaches to
test the requirement of key signaling pathways.

1.8 Conclusions and perspective
Many signaling pathways are activated during tissue regeneration and limb
development in vertebrates. Studies have shown that TGF-β, Wnt, and Fgf signaling
pathways are among the most important pathways controlling processes that are
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necessary for limb development, including limb bud initiation, cell proliferation, and
patterning. These pathways also play essential roles in regulating processes during
tissue regeneration, including the formation of the wound epithelium, stimulation and
migration of progenitor cells, and progenitor cell proliferation. Functional studies are
needed to test the requirement of TGF-β, Wnt, and Fgf signaling pathways during
limb development and tail regeneration.

1.9 Rationale
Recently, a chemical screen was performed to identify molecules that alter molecular
functions, signaling pathways, and biological processes associated with axolotl tail
regeneration (Ponomareva et al. 2015). Three specific inhibitors SB505124, Wnt-C59
and BGJ398 targeting TGF-β, Wnt, and Fgf signaling pathways, respectively, were
found to block axolotl tail regeneration. In this dissertation, I performed experiments
to determine how these chemical inhibitors affected processes that are necessary for
tail regeneration, including mitosis, cell proliferation, and cell orientation during
axolotl tail regeneration and limb bud outgrowth.

20

CHAPTER 2 TGF-β SIGNALING IS REQUIRED DURING AXOLOTL TAIL
REGENERATION
Qingchao Qiu1
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2.1 Abstract
The Tgf-β signaling pathway is required for many regenerative processes in
vertebrates, including salamander limb, frog tadpole tail, and fish fin regeneration.
Here, I investigated the requirement of Tgf-β signaling pathway on tail regeneration
using Mexican axolotl (Ambystoma mexicanum) embryos and chemical inhibitors of
Smad and non-Smad signaling pathways (SB505124 and Naringenin). Both
SB505124 and Naringenin completely blocked tail regeneration and reduced levels of
p-Smad2 and p-Smad3 as early as 1-hour post-amputation. However, more complex
changes in p-Erk and p-Akt were observed between the chemical treatments. At 1hpa,
levels of p-Erk and p-Akt were significantly higher in SB505124-treated embryos, but
significantly lower in Naringenin-treated embryos. At 6hpa and 12hpa, SB505124
significantly affected levels of p-Erk while Naringenin significantly affected levels of
p-Akt. Further analyses showed that SB505124 but not Naringenin decreased cell
proliferation. My results show that Tgf-β signaling pathway via Smad and non-Smad
signaling pathways are activated very early after axolotl tail amputation and chemical
perturbation of these pathways blocks tail regeneration. Overall, my study enriches
the understanding of signaling network dynamics that underlie tissue regeneration.
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2.2 Introduction
Multiple signaling pathways are deployed during regeneration to regulate cellular and
developmental processes associated with repair and formation of new tissue (Ho and
Whitman 2008; Singh et al. 2018; Peiris et al. 2016; Herman et al. 2018). Detailing
where and when signaling pathways are deployed during regeneration is essential to
understand how regeneration programs are regulated. Cellular and developmental
processes are often regulated in parallel, and it can be difficult to resolve the onset or
offset timing of signaling pathway deployment in rapidly developing model
organisms (Fields and Johnston 2005). To address this issue, we recently developed
an embryo tail amputation model using the Mexican axolotl (Ponomareva et al. 2015).
The assay uses hatching stage embryos that are capable of regenerating amputated
distal tail tips in 7 days. Relative to rapidly growing organisms like Danio rerio
(zebrafish) and Xenopus laevis (Xenopus), axolotl embryos grow slowly, allowing
greater temporal resolution of early events during regeneration (Fields and Johnston
2005; Voss, Epperlein, and Tanaka 2009).

The axolotl embryo model was first used to investigate the Wnt signaling pathway
during tail regeneration (Ponomareva et al. 2015). Wnt proteins are secreted ligands
that bind to extra-cellular receptors of the Frizzled family (Willert and Nusse 2012;
MacDonald and He 2012). In the presence of Wnt ligand, intracellular levels of βCatenin increase, and transcriptional target genes are activated (MacDonald, Tamai,
and He 2009). Using chemical compound Wnt-C59, a potent inhibitor of Wnt ligand
secretion, Ponomareva et al (2015) inhibited tail regeneration, thus establishing a
requirement for Wnt signaling. Surprisingly, few differentially expressed genes were
discovered between Wnt-C59 treated and control embryos before 48 hours post-
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amputation. Still, the few genes that were discovered at 24hpa and the greater number
of genes discovered at later time points included many ligands and components of cell
signaling pathways (e.g. Wnt, Fgf, Bmp, Tgf-β, Egf, Ras/Mapk, Ngf, Notch, Ra, Myc,
and P53) (Ponomareva et al. 2015). Thus, Wnt signaling yields transcripts that code
for proteins of multiple signaling pathways, but the timing is delayed relative to early
wound healing events (< 24hpa) that are likely regulated by other signaling pathways
(Shah et al. 2012).

A pathway that is likely activated upstream of Wnt during tail regeneration is the Tgfβ signaling pathway, as it is known to be activated very early in response to injury,
and it is required for successful zebrafish fin, Xenopus tadpole tail, and axolotl limb
regeneration (Levesque et al. 2007; Ho and Whitman 2008; Denis et al. 2016;
Pfefferli and Jazwinska 2017). Tgf-β signaling is generally mediated by Tgf-β, Nodal
and Activin ligands that bind Tgf-β type II receptors on the cell membrane, causing
the recruitment and transphosphorylation of Tgf-β type I receptors (Aykul and
Martinez-Hackert 2016; Zhu et al. 2012; Wrana et al. 1992; Attisano et al. 1993).
Activated Tgf-β type I receptors phosphorylate Smad2 and Smad3, which then
complex with Smad4, a co-Smad that mediates translocation into the nucleus to
regulate transcription (Derynck and Zhang 2003). In addition to canonical
Smad2/Smad3 signaling, the Tgf-β signaling pathway utilizes non-Smad pathways,
including Map kinase and phosphatidylinositol-3-kinase/Akt (Zhang 2009; Li et al.
2013; Li et al. 2016). Recently, inhibitors of Smad3 were used to show that p-Smad2
but not p-Smad3 mediates Tgf-β signaling during axolotl limb regeneration (Denis et
al. 2016). Whether this mechanism generally applies to animal models with
regenerative capacity, as well as other tissues in the axolotl, is unknown.
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In this study, I used chemical compounds to inhibit components of the Tgf-β signaling
pathway during axolotl embryo tail regeneration. I show that SB505124 and
Naringenin both inhibit tail regeneration, and this is associated with alterations in
canonical Smad2/3 signaling and non-Smad signaling pathways. Interestingly, only
SB505124 inhibited cell proliferation and thus the mechanism by which Naringenin
inhibited regeneration remains unknown.

2.3 Materials and Methods
2.3.1 Regeneration experiments
Axolotl embryos were reared at 16°C in 40% Holtfreter’s solution. Embryos at
developmental stage 42 (Bordzilovskaya & Dettlaff, 1989) were used for all the tail
regeneration experiments (Ponomareva et al. 2015). SB505124 (Selleckchem, Cat.
#S2186) was dissolved in DMSO to make a 50mM stock solution and used at 10μM
for regeneration experiments (DaCosta Byfield et al. 2004). DMSO at 0.02% was
used for controls. Naringenin (Selleckchem, Cat. #S2394) was dissolved in DMSO to
make a 50mM stock solution and used at 20μM for the regeneration experiments
(Denis et al. 2016). DMSO at 0.04% was used as controls for Naringenin treatment to
match the DMSO concentration in the treatment group. Axolotl embryos were
dechorionated and anesthetized in 0.02% benzocaine, and 2mm of the distal tail tip
was amputated using a sterile blade. Embryos were reared singly, one per well, in 12well microtiter plates for the timing experiments and immunofluorescence (IF)
staining. Five embryos were reared per well for Western Blot tissue collection. There
were 9 groups in the titration experiment: 0.02% DMSO control, and 10-4, 10-3, 10-2,
10-1, 1, 2.5, 5, and 10µM SB505124. There were 7 groups in the timing experiment:
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0.02% DMSO control and SB505124 administered from 0-12, 12-24, 24-48, 48-72,
72-120, and 120-144hpa. The embryos were photographed at different postamputation time points, and tail length and snout-vent length were measured from the
images. Statistical analysis was performed using GraphPad Prism software version 6.0
using Student’s t-test.

2.3.2 Antibodies
Anti-TGF-β antibody (Cat. #bs-0086R) was obtained from Bioss. Anti-p-Smad2 (Cat.
#3108), Anti-Smad2 (Cat. #5339S), Anti-Smad3 (Cat. #9523S), Anti-Erk (Cat.
#4348), Anti-phospho-Erk (Thr202/Tyr204) (Cat. #4370), Anti-Akt (Cat. #9272),
Anti-phospho-Akt (Ser473) (Cat. #9271), Anti-β-Actin (Cat. #5125S), and AntiGAPDH (Cat# 2118) were purchased from Cell Signaling Technology. Anti-p-Smad3
was a gift from Dr. Stephane Roy (Succursal Centresville Montreal, Quebec Canada).
Anti-phospho-Histone H3 (Ser10) (Cat. # 05-1336) was purchased from Millipore.
Goat anti-Rabbit IgG, (H+L) HRP conjugate (Cat. # AP307P) and Goat anti-Mouse
IgG, (H+L) HRP-conjugated secondary antibodies (Cat. #AP308P) were purchased
from Millipore. Cy3™ AffiniPure Donkey Anti-Mouse IgG (H+L) (Cat. #715-165151) was purchased from Jackson Immune Research. DAPI (4', 6-diamidino-2phenylindole, dihydrochloride, Cat. #62247) was purchased from Thermo Scientific.

2.3.3 Immunochemistry staining
A previous protocol was modified for immunochemistry staining (Qiu et al. 2015). In
brief, samples were fixed in 4% Paraformaldehyde (PFA) overnight. Samples were
dehydrated through a methanol series, starting in 100% PBS and then 25, 50, 75, and
100% methanol. These samples were saved at -20ºC for later use. Samples were
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rehydrated for whole-mount staining or OCT embedding. After OCT embedding,
8μM sections were prepared for staining or saved at -80°C for later use. Primary AntiTGF-β 1antibodies were used at 1: 200. Primary Anti-phospho-Histone H3 (Ser10)
antibodies were used at 1:1000. The secondary Cy3™ AffiniPure Donkey AntiMouse IgG (H+L) antibodies were used at 1:200. Blocking solution was 5% sheep
serum. Total DNA was labeled by DAPI. Stained slides were imaged using a confocal
microscope (Nikon Tie and C2+ Confocal). A mitotic index was determined by
dividing the number of histone H3 positive cells by the number of DAPI positive cells
within 200μm of the tail tip. Statistical analysis was performed using GraphPad Prism
software version 6.0 using Student’s t-test.

2.3.4 Western blotting
Embryos that had been administered tail amputations were anesthetized with 0.02%
benzocaine and 1mm of the distal tail tip was cut using a sterile blade. Tail tips of 30
embryos were pooled for each sample. The pooled tail tips were washed two times
using 1x PBS solution with proteinase/phosphatase inhibitor mixture (#5872S, Cell
Signaling Technology), and then lysed in RIPA buffer (#R0278, Sigma) with
proteinase/phosphatase inhibitor mixture by using a 22.5-gauge needle and 1 ml
syringe. The protein concentrations were determined by a BCA protein assay
(#23225, Thermo Scientific). Equal amounts of tissue lysate were loaded into lanes of
10% SDS polyacrylamide gels and transferred to PVDF membranes. The membranes
were blotted with 5% non-fat milk and then incubated overnight at 4°C with primary
antibodies and were followed by HRP-conjugated secondary antibodies. The immune
complexes were detected by enhanced chemiluminescence (Cat# NEL103001,
PerkinElmer). Quantification of band intensities was performed using the ImageJ
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software (http://rsbweb.nih.gov/ij/). The data were shown as mean ± SD. Statistical
analyses were performed by GraphPad Prism software version 6.0. using Student’s ttest.

2.3.5 EdU cell proliferation assay
An EdU cell proliferation assay was performed using FAM picolyl azide from Click
Chemistry Tools (Cat. # 1180-1), along with CuSO4 and sodium ascorbate in the
Click-iTTM EdU Alexa FluorTM 488 Imaging Kit from Invitrogen (Cat. # C-10337).
The protocol was modified for whole-mount staining and cryo-section staining.
Briefly, axolotl embryos were tail amputated and placed in 12-well-plates with 0.02%
DMSO, 0.04% DMSO, 10μM SB505124, or 20µM Naringenin solution. At 48hpa,
embryos were injected intraperitoneally with 1ul of 8μM 5-ethynyl-2’-deoxyuridine
(EdU). At 72hpa, embryos were anesthetized with 0.02% benzocaine and fixed in 4%
paraformaldehyde overnight. The samples were dehydrated and rehydrated using a
methanol series (0, 25, 50, 75, and 100% in PBS). The samples were washed with
PBS with 1% Triton for 3x5 minutes, then bathed in 2.5% trypsin for 30 minutes and
washed with icy cold acetone for 10 minutes following PBS with 1% Triton 3x5
minutes. Click-iT EdU reaction solution containing 1x Tris-buffered saline, 4mM
CuSO4, FAM 488 picolyl azide, and 100mM sodium ascorbate was used to visualize
EdU incorporation into the DNA of proliferating cells. DAPI was used to counter
stain DNA within cells. Cells staining positive for EdU within 400µm of the tail tip
were counted as well as cells staining positive for DAPI within the same area. A
proliferative index was calculated as a ratio of EdU positive cells over DAPI positive
cells. For cryo-section staining, trypsinization and ice-cold acetone washing steps

27

were skipped. Results were analyzed in GraphPad Prism software version 6.0 (San
Diego California USA) using Student’s t-test.

2.4 Results
2.4.1 Tgf-β signaling is required during axolotl tail regeneration.
A Tgf-β receptor Alk5/4/7 inhibitor, SB505124, was previously shown to inhibit
axolotl tail regeneration using a 10µM dose (Ponomareva et al. 2015; DaCosta
Byfield et al. 2004). To verify this result and more comprehensively examine dosage,
I treated embryos with different concentrations of SB505124 (0, 10-4, 10-3, 10-2, 10-1,
1, 2.5, 5, and 10µM) (Figure2.1 A). The treated embryos appeared healthy and active
for all treatments tested. Doses of SB505124 above 0.01µM inhibited tail regeneration
at 7dpa (Figure2.1 B). By varying the time that SB505124 was administered, I
detected significant differences in tail length at 7dpa when treating embryos from 012hpa, 12-24hpa, and 48-72hpa (Figure2.1 C). In contrast, I did not detect significant
differences in snout-vent length at 7dpa (Figure2.1 D). These results show that
SB505124 efficiently blocks tail regeneration without affecting overall embryo
growth and development. These results suggest that Tgf-β signaling is required for
axolotl tail regeneration.

To further investigate the requirement of Tgf-β signaling, I treated embryos with
Naringenin, a small molecule that inhibits phosphorylation of Smad3, an intracellular
protein that mediates Tgf-β signal transduction (Ortiz-Andrade et al. 2008; Denis et
al. 2016). I tested 8 embryos for 4 different concentrations of Naringenin (0, 10, 20,
and 35µM) (Figure2.2 A-C). The 35µM treatment was toxic, all embryos died.
Relative to controls, embryos treated with 10µM showed a marginal decrease in tail
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length at 7dpa, indicating partial inhibition of regeneration. In contrast, 20µM
Naringenin significantly inhibited tail regeneration at 7dpa (Figure2.2 D). Although
the 20µM treated embryos appeared healthy and normal, I noted that the outer
margins of their tailfins presented an abnormal white coloration. This white tissue
may reflect necrosis of epithelial cells during prolonged treatment of Naringenin at
20µM. However, Naringenin completely inhibited regeneration at this concentration,
consistent with an early disruption of the Tgf-β signaling pathway.

Figure 2.1 Inhibiting Alk4/5/7 by SB505124 blocks axolotl tail regeneration.
A and B) SB505124 treatments above 0.01µM significantly inhibited axolotl embryo
tail regeneration. C) 10µM of SB505124 was administered at different time periods
and tail length was measured. Tail length at 7dpa differed significantly between
DMSO treated controls (1.53 ± 0.26mm) and SB505124 treatments of 0-12 (0.54 ±
0.29mm), 12-24 (1.01 ± 0.03mm), and 48-72hpa (0.90 ± 0.22mm). D) No significant
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difference in snout-vent length was detected between SB505124 treated and DMSO
treated controls. *: p value < 0.05 for contrasts of DMSO control vs SB505124.

Figure 2.2 Naringenin inhibits axolotl tail regeneration.
A-D) Naringenin inhibited axolotl tail regeneration at 7dpa. D) Tail growth was
significantly less for 20µM Naringenin treated embryos (0.92 ± 0.22mm) relative to
DMSO controls (2.45 ± 0.38mm). *: p value < 0.001 for contrasts of DMSO control
vs Naringenin.

2.4.2 Tgf-β1 increases during tail regeneration.
Previous studies have established that the Tgf-β signaling pathway is required for
axolotl limb regeneration (Levesque et al. 2007; Jhamb et al. 2011; Denis et al. 2016).
In particular, Levesque et al. (2007) showed that Tgf-β1 mRNA is upregulated very
early (6hpa) following limb amputation and strongly expressed in the blastema at the
early bud stage. To determine if Tgf-β1 is also expressed during axolotl embryo tail
regeneration, I stained for Tgf-β1 at 0, 3, and 6hpa. Tgf-β1 was broadly expressed in
the tail at the time of amputation, particularly in the epidermis and myotomes
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(Figure2.3 A). Tgf-β1 expression significantly decreased at 3hpa (Figure2.3 A-D, n =
6, p < 0.05) but was significantly higher than basal levels at 6hpa, prominently in cells
of the wound epidermis (Figure2.3 A-D, n = 6, p < 0.05). These data show that Tgf-β1
is dynamically regulated in response to tail amputation.

Figure 2.3 Tgf-β1 is broadly expressed in the axolotl tail and increases in the
epidermis during tail regeneration.
A) Tgf-β1 expression at 0hpa in the tail tip. Relative to Tgf-β1 expression in the
epidermis at 0hpa, expression was significantly lower at 3hpa (B) but significantly
higher at 6hpa (C). * p < 0.001 for contrasts of DMSO control vs SB505124. MM:
Mesenchymal tissue; SC: Spinal cord; NC: Notochord; MC: Muscle cells; ED:
Epidermis tissue. SCA: Spinal cord ampulla.
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2.4.3 Smad-mediated Tgf-β signaling increases during axolotl tail regeneration.
Tgf-β signaling during axolotl limb regeneration is associated with phosphorylation of
Smad2 and Smad3 (Denis et al 2016). To determine if Smad2/3-mediated Tgf-β
signaling during axolotl tail regeneration, I quantified phosphorylated Smad2 (pSmad2) and Smad3 (p-Smad3) expression using pooled 2 mm tail tips by Western
Blotting. Levels of Smad2 and Smad3 were constant for all samples analyzed, while
p-Smad2 and p-Smad3 levels were more variable (Figure2.4A). P-Smad2 increased
from 1hpa to 12hpa (Figure2.6 A and B) while the expression of p-Smad3 was
relatively constant (Figure2.4A and C). Embryos were next treated with SB505124 to
determine if p-Smad2 and p-Smad3 were specifically mediated by Tgf-β signaling, in
comparison to control embryos; SB505124 significantly decreased p-Smad2 at 1, 6,
and 12hpa (45.1%, 71.1%, and 74.5%, respectively) (Figure2.4 A and B). P-Smad3
was not significantly inhibited by SB505124 at 1 h, but p-Smad3 levels were
significantly lower at 6 and 12hpa (57.9% and 36.9%, respectively) (Figure2.4A-C).
The results show that SB505124 treatment affected p-Smad2 earlier and to a greater
degree than p-Smad3, but inhibition of Tgf-β signaling decreased phosphorylation of
both proteins.

I next performed Western blotting to determine if Naringenin inhibited tail
regeneration via its predicted blockade of Smad3 phosphorylation (Denis et al. 2016).
In control embryos, p-Smad2 levels increased slightly at 1hpa, but greatly at 6 and
12hpa. At each of these time points, Naringenin treated embryos showed significantly
reduced levels of p-Smad2 (Figure2.5 A and B). The p-Smad3 expression profiles for
control and treated embryos also showed differences in both timing and magnitude of
expression. In control embryos, p-Smad3 increased precipitously at 1hpa, but after
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this time levels decreased. Levels of p-Smad3 also increased in Naringenin treated
embryos. However, peak expression was observed at 6hpa. As a result, p-Smad3
levels were significantly lower in Naringenin treated embryos at 1hpa, but
significantly higher than those of controls at 6hpa (Figure2.5 A and C). Thus,
Naringenin decreases and delays p-Smad3 expression after tail amputation. Overall,
these expression patterns show that Naringenin alters phosphorylation dynamics of
Smad2 and Smad3 proteins that mediate Tgf-β signaling.

Figure 2.4 SB505124 significantly affects p-Smad2 and p-Smad3 expression.
A) Smad2, p-Smad2, Smad3, and p-Smad3 were detected by Western blotting using
pooled 1mm tail tips from SB505124 treated or DMSO control embryos at 0, 1, 6, and
12hpa. B) P-Smad2 expression was normalized against total Smad2. C) P-Smad3
expression was normalized against total Smad3. *: p-value < 0.05 for contrasts of
DMSO control vs SB505124.
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Figure 2.5 Naringenin significantly affects activation of Smad2 and Smad3. A)
Western blotting of Smad3, p-Smad3, Smad2, and p-Smad2 using pooled 1mm tail
tips from 20µM Naringenin (NA) treated or DMSO treated embryos tail tips collected
at 0, 1, 6, and 12hpa. B) P-Smad2 expression was normalized against total Smad2. C)
P-Smad3 expression was normalized against total Smad3. *: p-value < 0.05 for
contrasts of DMSO control vs Naringenin.

2.4.4 Non-Smad mediated Tgf-β signaling pathways are up-regulated by SB505124
and down-regulated by Naringenin at 1hpa.
Previous studies have shown that Tgf-β ligands mediate intracellular signaling via
non-Smad mediated pathways (Ho and Whitman 2008; Bassat et al. 2017; Bakin et al.
2000). To investigate non-Smad mediated Tgf-β signaling pathways, phosphorylated
Erk (p-Erk) and Akt (p-Akt) signaling were quantified by Western blotting. Both pErk and p-Akt were detected at the time of tail amputation. However, these proteins
presented different post-amputation expression profiles between control and
SB505124-treated tails. While p-Erk was increased in both control and SB505124-
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treated embryos at 1hpa, expression was significantly higher in the later (Figure2.6 A
and B). Phosphorylated Akt did not significantly change at 1hpa but decreased at 6
and 12hpa in control embryos. SB505124 treatment increased Akt phosphorylation at
1hpa and had no significant effect at 6 and 12hpa (Figure2.6 A and C). P-Erk was
significantly down-regulated in Naringenin-treated embryos at 1hpa compared with
controls (Figure2.7 A and B). Naringenin also significantly down-regulated p-Akt
following tail amputation at all time points (Figure2.7 A and C). These results show
that Erk and Akt activation are up-regulated by SB505124 and down-regulated by
Naringenin during early tail regeneration.

Figure 2.6 SB505124 increases phosphorylation of non-Smad mediated signaling Erk
and Akt at 1hpa. A) Erk, p-Erk, Akt, p-Akt, and β-actin were detected by Western
blotting using pooled 1mm tail tips from SB505124 treated or DMSO control
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embryos at 0, 1, 6, and 12hpa. B) P-Erk expression was normalized against Erk. C) PAkt expression was normalized against Akt. *: p-value <0.05 for contrasts of DMSO
control vs SB505124.

Figure 2.7 Naringenin down-regulates p-Erk and p-Akt signaling at 1hpa. A) Western
blotting of total Erk, p-Erk, Akt, p-Akt, and β-actin using pooled 1mm tail tips from
Naringenin treated or DMSO control tails. B) P-Erk expression was normalized
against Erk. C) P-Akt expression was normalized against Akt. *: p value < 0.05 for
contrasts of DMSO control vs Naringenin.

2.4.5 SB505124, but not Naringenin, significantly reduces cell proliferation.
Tgf-β signaling pathway is required for cell proliferation during tail regeneration in
Xenopus laevis tadpoles (Ho and Whitman 2008). To determine whether Tgf-β
signaling regulates cell proliferation during axolotl tail regeneration, EdU
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incorporation was used to detect proliferating cells from 48 to 72hpa. In DMSO
control tails, proliferating cells were observed in the regenerating bud, especially
within 400µm of the tail tip (Figure2.8 A-A’’), while SB505124 treatment reduced
cell proliferation within multiple regions of the tail including dorsal fins, ventral fins,
and spinal cord (Figure2.8 B-B’’ and D, n = 6, p < 0.001). In contrast, Naringenin
treatment did not reduce cell proliferation significantly in these tissues (Figure2.8 CC’’ and E, n = 4, p > 0.05). These data show that SB505124 downregulates cell
proliferation during tail regeneration, while Naringenin does not.
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Figure 2.8 SB505124, but not Naringenin, significantly reduces cell proliferation at
72hpa. Images A”, B”, and C” are cryo-sections of regenerating tails. All the other
images are the whole-mount and regenerating tails. A) DMSO control stained for
EdU. A’) DMSO control stained with DAPI. A’’) DMSO control stained for EdU and
DAPI. B) Tail treated with SB505124 and stained for EdU. B’) Tail treated with
SB505124 and stained with DAPI. B’’) Tail treated with SB505124 and stained for
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EdU and DAPI. C) Tail treated with Naringenin and stained for EdU. C’) Tail treated
with Naringenin and stained with DAPI. C’’) Tail treated with Naringenin and stained
with EdU and DAPI. D) Proliferative index for the tail tip and spinal cord. For dorsal
or ventral fins, cells were counted in whole-mount staining samples. E) Proliferative
index for Naringenin treated and control samples. *: p-value < 0.001 for contrasts of
DMSO control vs SB505124.

2.4.6 Tgf-β signaling regulates cell mitosis during tail regeneration.
To determine whether the cell proliferation response during tail regeneration
associates with cell mitosis, a mitotic marker, anti-phospho-histone H3 (Ser10), was
used to detect mitotic cells. In DMSO treated controls, the mitotic index was 7.6 ±
2.8%. SB505124 treatment significantly reduced the mitotic index to 2.4 ± 1.0%
(Figure2.9 A-C, n = 3, p < 0.05). These results strongly suggest that Tgf-β signaling
regulates cell mitosis during tail regeneration.

Figure 2.9 SB505124 inhibits the mitotic index within tail tips at 48hpa. A) DMSO
control tail stained with phospho-histone H3 in red. The total nuclear DNA was
labeled with DAPI. The white stippled lines outline the tail. B) SB505124 treated tail
stained with phospho-histone H3. C) Graph comparing the mitotic index in DMSO
control and SB505124 treated tails. *: p-value < 0.05 for contrasts of DMSO control
vs SB505124.
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2.5 Discussion
Ligands of the Tgf-β super family associate with axolotl tail regeneration.
Tgf-β ligands are pleiotropic cytokines whose activities depend on their receptorbinding partner and intracellular signaling components. In mammals, there are
approximately 33 ligands in the Tgf-β family (Aykul and Martinez-Hackert 2016). In
this chapter, Tgf-β1 was shown to be up-regulated during axolotl tail regeneration.
This result is consistent with studies of other tissue regeneration models. For example,
Tgf-β1 is upregulated during axolotl limb and tadpole tail regeneration (Denis et al.
2016; Levesque et al. 2007). However, SB505124 inhibits multiple type I receptors
(Alk5/4/7). Ligands, in addition to Tgf-β1, which are thought to signal through Alk5,
may orchestrate Tgf-β signaling during axolotl tail regeneration. For example, Tgf-β2
and Tgf-β5 are up-regulated during Xenopus tail regeneration, and they are thought to
function in wound epithelium formation and establishment of the regeneration bud, a
structure that forms very early in tadpole regeneration (Ho and Whitman 2008). Also,
these Tgf-β ligands are thought to regulate cell proliferation through their effects on
Erk signaling (Ho and Whitman 2008). In lizard tail regeneration, Tgf-β1 expression
is limited while activin-βA is strongly upregulated. Morpholino knockdown of
activin-βA or its receptor Alk4 impairs zebrafish fin regeneration (Jazwinska,
Badakov, and Keating 2007). Inhibin could be another important ligand during tail
regeneration based on results of a previous axolotl tail microarray study which
showed significant upregulation of inhbb at 48hpa (Ponomareva et al. 2015). Inhbb
shares a β subunit with activin and its function is thought to oppose activin (Zhu et al.
2012; Namwanje and Brown 2016). In future studies, it will be important to
investigate activin and inhibin during axolotl tail regeneration. Overall, my results and
other studies clearly implicate Tgf-β ligands in early tissue regeneration responses.
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Dynamic regulation of p-Smad2 and p-Smad3 by Tgf-β signaling during tail
regeneration
In this study, I showed that chemical disruption of Tgf-β signaling altered Smad2 and
Smad3 phosphorylation. In control embryos, p-Smad2 and p-Smad3 dynamically
increased following tail amputation. Both Smad2 and Smad3 were activated upon tail
amputation as early as 1hpa and p-Smad2 steadily increased after this time while pSmad3 decreased. Application of SB505124 down-regulated both p-Smad2 and pSmad3 at all post-amputation time points and blocked tail regeneration. Naringenin
also down-regulated p-Smad2 at all post-amputation time points and delayed peak pSmad3 expression and completely blocked tail regeneration. However, SB505124
treatment affected p-Smad2 at an earlier time and to a greater degree than p-Smad3,
while Naringenin affected p-Smad3 at an earlier time and to a greater degree than pSmad2. Activation of p-Smad2 has been reported at 1hpa during Xenopus tail
regeneration and 6hpa during axolotl limb regeneration; these results are consistent
with my findings (Ho and Whitman 2008; Denis et al. 2016). Denis et, al (2016)
reported that only phosphorylation of Smad2, but not phosphorylation of Smad3, is
required for axolotl limb regeneration (Denis et al. 2016). This contrasts with my
findings, as I found that pSmad3 inhibitor Naringenin blocked tail regeneration.
Additional studies are needed to understand the differential requirements for Smad2
and Smad3 signaling during axolotl limb and tail regeneration.
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Dynamic regulation of p-Erk and p-Akt by the Tgf-β signaling pathway during
tail regeneration
Erk and Akt are two non-Smad mediated Tgf-β signaling pathways (Zhang 2009). Erk
signaling is a central cassette of the mitogen-activated protein kinase (Mapk)
signaling pathway that regulates mammalian wound contraction and cell proliferation
(Shaul and Seger 2007; Li et al. 2013; Li et al. 2016). Tgf-β signaling also activates
Akt signaling; inhibition of Tgf-β type I receptor prevented the activation of Akt that
functions in mammalian cell survival (Bakin et al. 2000). In this study, I found that pErk and p-Akt responded to tail amputation at an early phase of tail regeneration. In
DMSO control embryos, the expression pattern of p-Erk and p-Akt in SB505124 and
Naringenin were different. One possible reason is that embryos used for these
different experiments came from different genetic backgrounds that may exhibit
variability in cell signaling. Another possible reason is that the DMSO concentration
in the Naringenin experiments was 0.04%, which is 1x higher than the DMSO
concentration in the SB505124 experiment. Studies have shown that DMSO
concentration may differentially alter cell membrane structure, ubiquitination sites,
and affect oxidative phosphorylation (ATP synthesis) leading to variation in signal
transduction, protein degradation, and protein phosphorylation (Majdi et al. 2017;
Doellinger et al. 2018; Syed, Skonberg, and Hansen 2013; Julien et al. 2012).
However, the effects of DMSO on axolotl cells is unknown. In regard to protein
phosphorylation, I used a high concentration of proteinase/phosphatase inhibitor
during sample collection. Despite differences in the expression levels of p-Erk and pAkt in the DMSO controls, their patterns were somewhat similar for the first 6hpa. In
both of the DMSO control samples, p-Erk was expressed at the time of tail
amputation, increased at 1hpa and then decreased at 6hpa, although the decrease was
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much greater in the Naringenin experiment. P-Akt was expressed at the time of tail
amputation. It changed very little at 1hpa and decreased at 6hpa. These data suggest
that both Erk and Akt were dynamically changed following tail regeneration. Overall,
increased expression of p-Erk and decreased expression of p-Akt appear to be
important early signaling responses. Furthermore, p-Erk and p-Akt were significantly
up-regulated in SB505124-treated tails, but significantly down-regulated in
Naringenin-treated tails at 1hpa, showing that p-Erk and p-Akt are affected by
disruptions of Tgf-β signaling. Temporal changes in p-Erk and p-Akt have been
observed in other studies. For example, Erk phosphorylation is upregulated in the
wound epithelium at 8hpa and in mesenchymal cells under the wound epithelium at
48hpa during Xenopus tail regeneration (Ho and Whitman 2008). These two periods
of Erk phosphorylation are consistent with my results which showed inhibition of tail
regeneration at these times. The first 0-24 hours is an important injury response phase
wherein genes are expressed to facilitate wound healing. Transcription between 4872hpa time course may regulate cell proliferation. Also, in the Xenopus limb
regeneration model, Erk phosphorylation is upregulated in the wound epithelium at
48hpa and mesenchymal cells under the wound epithelium at 96hpa while Akt
phosphorylation is up-regulated in the mesenchymal cells from 24hpa to 96hpa
(Suzuki et al. 2007). Overall, these studies suggest an important role for pathways that
mediate non-Smad Tgf-β signaling during early amphibian appendage regeneration.

Tgf-β signaling regulates mitogenic activity and cell proliferation response
during axolotl tail regeneration.
In cell culture models, it is widely accepted that Tgf-β signaling inhibits the growth of
certain non-transformed epithelial, endothelial, and primary fibroblasts of embryonic
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origin (Moses 1992; Ten Dijke et al. 2002). However, Tgf-β signaling facilitates
mitogenic activity in some transformed cells and immortalized fibroblasts
(Alexandrow and Moses 1995). In cancer biology, it is known that the action of Tgf-β
signaling depends on cell type and growth conditions; it acts as a tumor suppressor at
early stages and stimulates tumor proliferation at later stages (Fabregat et al. 2014). In
tissue regeneration models, Tgf-β pathway regulation of cell proliferation is also
tissue-dependent. In zebrafish, Tgf-β signaling promotes cell proliferation during fin
and heart regeneration, but negatively regulates cell proliferation in retinal
regeneration (Tappeiner et al. 2016). In axolotl tail regeneration, I detected
significantly higher cell proliferation and mitosis in control embryos than in
SB505124 treated embryos at 72hpa and 48hpa, respectively. Therefore, my data
indicate that Tgf-β signaling plays an important role in regulating cell proliferation
responses during tail regeneration.

Naringenin targets multiple signaling pathways in addition to p-Smad3
phosphorylation.
Naringenin inhibited p-Smad2, p-Smad3, p-Erk, and p-Akt as early as 1hpa, and
blocked tail regeneration. The inhibitory effect of Naringenin on axolotl tail
regeneration contrasts with the result of Denis et al (2016), who did not find that
Naringenin inhibited axolotl limb regeneration. They concluded that p-Smad3 is not
required during axolotl limb regeneration while my result suggests that p-Smad3 is
required for axolotl tail regeneration. It is possible that Naringenin may have a
broader inhibitory effect in the axolotl embryo model than the adult limb model, as
multiple signaling pathways are operative during early development. In other words,
Naringenin targets multiple signaling pathways in addition to p-Smad3. Consistent
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with this interpretation, my study is the first to show that Naringenin downregulates pSmad2, p-Erk, and p-Akt during tissue regeneration.

A cell proliferation response at 72hpa is necessary, but not sufficient for tail
regeneration.
SB505124 treatment decreased cell proliferation at 72hpa and prevented tail
regeneration. These results suggest that Tgf-β signaling regulates a cell proliferation
response that is necessary for successful tail regeneration. However, other processes
than cell proliferation are necessary for tail regeneration because Naringenin did not
inhibit cell proliferation at 72hpa but did block tail regeneration. It will be important
in future studies to perform dose and timing experiments for Naringenin to identify
the key periods for Naringenin inhibition of tail regeneration and more thoroughly
investigate how this drug affects cell mitosis.

In this chapter, I found: 1) Tgf-β1 is upregulated during tail regeneration. 2) Both
Smad mediated Tgf-β signaling and non-Smad mediated Tgf-β signaling are activated
as early as 1hpa during axolotl tail regeneration. 3) Blocking Tgf-β signaling by
SB505124 or Naringenin prevents axolotl tail regeneration. 4) Tgf-β signaling
regulates cell proliferation and cell mitosis during axolotl tail regeneration. Overall,
my study enriches understanding of Tgf-β signaling pathway dynamics underlies
tissue regeneration.
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3.1 Abstract
Wnt signaling pathway is activated during tissue regeneration. Palmitoylation of Wnts
by Porcupine is critical for Wnt protein secretion and activity. Here I investigated the
requirement of Wnt signaling on tail regeneration using Mexican axolotl (Ambystoma
mexicanum) embryos and Porcupine inhibitor Wnt-C59. Continuous Wnt-C59
treatment completely blocked tail regeneration at 7 days post tail amputation (dpa).
Temporal dosing experiments showed that Wnt signaling is required from 0-120
hours post-amputation (hpa). Individuals that were removed from Wnt-C59 treatment
at 7dpa regenerated somatic tissues of the body axis, but not dorsal and ventral fins.
Strikingly, Wnt-C59 released individuals did not develop their forelimbs, and
hindlimb development was abnormal. Levels of Wnt3a were significantly lower than
pre-amputation levels at 24 and 72hpa. β-Catenin levels decreased in DMSO-treated
embryos after tail amputation and were significantly lower than pre-amputation levels
at 48hp, but significantly higher at 72hpa. Inhibiting Wnt signaling by Wnt-C59
increased the β-Catenin level and upregulated Erk and Akt phosphorylation.
Additionally, inhibition of Wnt signaling reduced cell mitosis at 24 hpa and cell
proliferation at 72hpa. These data suggest that Wnt signaling regulates β-Catenin,
Erk, and Akt signaling and controls cell mitosis and cell proliferation during axolotl
tail regeneration. My results show that Wnt signaling is required for axolotl tail
regeneration.
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3.2 Introduction
Salamanders regenerate many body parts including limbs, tail, lens, heart, spinal cord,
and brain (Sugiura et al. 2016; Nacu et al. 2016; Franklin, Voss, and Osborn 2017;
Suetsugu-Maki et al. 2012; Nakamura et al. 2016; Tazaki, Tanaka, and Fei 2017;
Amamoto et al. 2016). Salamander appendages harbor lineage-restricted progenitor
cells and multipotent cells that are recruited after injury to reform missing or damaged
tissues (Tanaka and Reddien 2011). For example, cell lineage tracing during Xenopus
tail regeneration showed that the spinal cord regenerates from progenitors within the
spinal cord, while new muscle is reformed by satellite cells within muscle tissue
(Gargioli and Slack 2004). Despite those advances in understanding tissue
regeneration at the cellular level, how injury activates signaling pathways to guide
progenitor cell behaviors is still poorly understood. For example, while it has been
established that Wnt signaling is required for axolotl embryo tail regeneration
(Ponomareva et al. 2015), the temporal requirements and effects of Wnt signaling on
cellular and developmental processes have not been characterized in this model.

Wnt proteins have been found to play a myriad of biological roles in controlling tissue
regeneration among many species (Zhao et al. 2019; Fan et al. 2018; Wischin et al.
2017; Ghosh et al. 2008; Kawakami et al. 2006). Wnt protein binds N-terminal
extracellular cysteine-rich domain of a 7 transmembrane molecule Frizzled (Fz)
family receptor, which interacts with co-receptors including lipoprotein receptorrelated (LRP) 5/6, ROR2, and receptor tyrosine kinase (RTK) (Komiya and Habas
2008). Upon activation, Fz directly binds to Dsh, which has three conserved protein
domains: a central PDZ domain, an amino-terminal DIX domain, and a carboxyterminal DEP domain (Wong et al. 2003). There are three Wnt signaling pathways:
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the canonical Wnt/β-Catenin pathway and two pathways that function independent of
β-Catenin, the Wnt/planar cell polarity (PCP) pathway and Wnt/calcium pathway
(Habas and Dawid 2005).

Canonical and non-canonical Wnt signaling pathways are required during tissue
regeneration to control different aspects of tissue regeneration (Kawakami et al. 2006;
Ghosh et al. 2008; Shimokawa et al. 2013; Hamilton, Sun, and Henry 2016;
Yokoyama et al. 2011; Sugiura et al. 2009; Lin and Slack 2008). Upon depletion of βCatenin, an amputated planarian tail regenerates into a head. This suggests that βCatenin maintains anteroposterior identity during homeostasis and regeneration in
planarians (Petersen and Reddien 2008; Gurley, Rink, and Sanchez Alvarado 2008).
Using a genetic construct to inhibit Wnt/β-Catenin signaling, Kawakami et al (2006)
prevented limb regeneration in axolotl larvae and fin regeneration in zebrafish.
Moreover, they showed that the surprising ability of early-stage chick embryos to
regenerate limbs is associated with β-Catenin signaling (Kawakami et al. 2006). Noncanonical Wnt signaling pathways are also crucial to regulate tissue regeneration.
Two non-canonical Wnt genes, Wnt5a and Wnt5b, are expressed during axolotl limb
regeneration (Ghosh et al. 2008). Overexpression of Wn5a induces the development
of ectopic tails in Xenopus tadpoles at the site of a dorsal incision; presumably, this is
mediated by Wnt/Jnk signaling (Sugiura et al. 2009). Thus, both canonical and noncanonical Wnt signaling pathways are required in multiple types of tissue
regeneration across species.

However, in some cases, the use of tools to inhibit Wnt signaling has not yielded
inhibitory regeneration outcomes. For example, a heat-shock inducible genetic
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construct encoding the Wnt antagonist Dkk1 did not prevent Xenopus limb or lens
regeneration (Yokoyama et al. 2011; Hamilton, Sun, and Henry 2016). Yokoyama et
al (2011) hypothesized that nerve-derived signals could compensate for Wnt signaling
during the initiation of Xenopus limb regeneration. Other studies have shown that
Wnt-pathway agonists can inhibit regeneration, including axolotl limb and Xenopus
lens regeneration (Wischin et al. 2017; Hamilton, Sun, and Henry 2016). In the
axolotl study, Wnt agonist treatment before blastema formation inhibits limb
regeneration, possibly by affecting innervation, while treatment after blastema
formation causes disorganized skeletal elements to form (Wischin et al. 2017). A
similar phenomenon has been shown during limb development; stabilization of βCatenin during early stages of limb development leads to early regression of the
apical epidermal ridge and results in truncated limbs (Hill et al. 2006), while it causes
skeletal abnormalities during later stages (Akiyama et al. 2004). During axolotl tail
regeneration, both Wnt agonist SKL, which increases Wnt/β-Catenin signaling, and
Wnt antagonist IWR-1-endo which decreases Wnt/β-Catenin signaling, inhibits tail
regeneration (Ponomareva et al. 2015). This suggests that successful tissue
regeneration requires proper spatial-temporal regulation of Wnt/β-Catenin signaling,
especially the timing of β-Catenin activation (Kawakami et al. 2006).

Ponomareva et al. (2015) found that inhibiting Wnt signaling pathway by Wnt-C59
blocks axolotl tail regeneration. Moreover, Wnt-C59 treatment affects transcription of
genes associated with Wnt, Fgf, Tgf-β, Hox, Egf, Myc, Notch, Ngf, Ras/Mapk, p53,
and retinoic acid (RA) pathways. Most differentially expressed genes were discovered
between Wnt-C59 treated and control embryos after 24 hours post tail amputation
(hpa). These data demonstrated that Wnt signaling interacts with other signaling
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pathways to regulate tail regeneration. However, the temporal requirement of Wnt/βCatenin signaling pathway during axolotl tail regeneration is unknown. In this study, I
used the chemical compound Wnt-C59 to inhibit Wnt protein secretion and activity
during axolotl embryo tail regeneration. I demonstrate that Wnt signaling is required
from 0 to 120 hours post tail amputation. The Wnt-C59 treatment completely
prevented tail regeneration, and this was associated with increasing β-Catenin, p-Erk,
p-Akt, and a reduction in cell mitosis and cell proliferation in the tail. These findings
suggest that Wnt/ β-Catenin signaling regulates p-Erk and p-Akt signaling pathways
to maintain cell mitosis and cell proliferative responses during axolotl tail
regeneration.

3.3 Methods
3.3.1 Regeneration experiments
Axolotl embryos were reared at 16°C in 40% Holtfreter’s solution. Embryos at
developmental stage 42 (Bordzilovskaya & Dettlaff, 1989) were used for all tail
regeneration experiments (Ponomareva et al. 2015). Wnt-C59 (Selleckchem, Cat.
#S7037) was dissolved in DMSO at 10mM to make a stock solution and then diluted
further to make a 10μM working solution. 0.1% DMSO was used for controls.
Axolotl embryos were dechorionated and anesthetized in 0.02% benzocaine, and 2mm
of tail tips were amputated using a sterile blade. Embryos were reared singly, one per
well, in 12-well microtiter plates for dose-timing experiments and
immunofluorescence (IF) staining. Five embryos were reared per well for tissue
collection to perform Western Blotting experiments. There were 7 groups in the
timing experiment: 0.1% DMSO control and Wnt-C59 administered from 0-12, 1224, 24-48, 48-72, 72-120, and 120-144hpa. The embryos were photographed at
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different post-amputation time points. Tail length and snout-vent length were
measured from the images. Statistical analyses were performed using GraphPad Prism
software version 6.0 using Student’s t-test.

3.3.2 Antibodies
Anti-β-Catenin (Cat. # 610154) was purchased from BD Biosciences. Anti-Wnt3a
(Cat. # bs-1700R), Anti-Erk (Cat. #4348), Anti-phospho-Erk (Thr202/Tyr204) (Cat.
#4370), Anti-Akt (Cat. #9272), Anti-phospho-Akt (Ser473) (Cat. #9271), and Anti-βactin (Cat. #5125S) were purchased from Cell Signaling Technology. Anti-phosphoHistone H3 (Ser10) (Cat. # 05-1336) was purchased from Millipore. Goat anti-Rabbit
IgG, (H+L) HRP conjugate (Cat. # AP307P) and Goat anti-Mouse IgG, (H+L) HRPconjugated secondary antibodies (Cat. #AP308P) were purchased from Millipore.
Cy3™ AffiniPure Donkey Anti-Mouse IgG (H+L) (Cat. #715-165-151) was
purchased from Jackson immune Research. DAPI (4', 6-diamidino-2-phenylindole,
dihydrochloride, Cat. #62247) was purchased from Thermo Scientific.

3.3.3 Tissue processing and immunochemistry staining
An existing protocol was modified for immunostaining (Qiu et al. 2015). In brief,
samples were fixed in 4% paraformaldehyde overnight. Samples were dehydrated
through a methanol series, starting in 100% PBS and then 25, 50, 75, and 100%
methanol. These samples were saved at -20ºC for later use. Samples were rehydrated
for whole-mount staining or OCT embedding. After OCT embedding, 8μM sections
were prepared for staining or saved at minus 80°C for later use. Primary Antiphospho-Histone H3 (Ser10) antibodies were used at 1:1000, and the secondary
Cy3™ AffiniPure Donkey Anti-Mouse IgG (H+L) antibodies were used at 1:200.
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Blocking solution was modified as 5% sheep serum. Total DNA was labeled by
DAPI. Stained slides were imaged using a confocal microscope (Nikon Tie and C2+
Confocal). A mitotic index was determined by dividing the number of histone H3
positive cells by the number of DAPI positive cells within 200μm of the tail tip.
Statistical analyses were performed using GraphPad Prism software version 6.0 using
Student’s t-test.

3.3.4 Western blotting
Embryos were anesthetized with 0.02% benzocaine and 1mm of the distal tail tip was
cut using a sterile blade. Tail tips of 30 embryos were pooled for each sample. Each
pooled sample was washed two times using a 1x PBS solution with
proteinase/phosphatase inhibitor mixture (#5872S, Cell Signaling Technology), and
then lysed in RIPA buffer (#R0278, Sigma) with proteinase/phosphatase inhibitor
mixture using a 22.5-gauge-needle and 1 ml syringe. Protein concentrations were
determined by a BCA protein assay (#23225, Thermo Scientific). Equal amounts of
tissue lysate were loaded into lanes of 10% SDS polyacrylamide gels and transferred
to a PVDF membrane. The membranes were blotted with 5% non-fat milk, incubated
overnight at 4°C with primary antibodies, and then incubated with HRP-conjugated
secondary antibodies. The immune complexes were detected by enhanced
chemiluminescence (Cat# NEL103001, PERKin Elmer). Quantification of band
intensities was performed using the ImageJ software (http://rsbweb.nih.gov/ij/). The
data were presented as the mean ± SD. Statistical analyses were performed using
GraphPad Prism software version 6.0 using Student’s t-test.

52

3.3.5 EdU cell proliferation assay
An EdU cell proliferation assay was performed using FAM picolyl azide from Click
Chemistry Tools (Cat. # 1180-1), along with CuSO4 and sodium ascorbate in the
Click-iTTM EdU Alexa FluorTM 488 Imaging Kit from Invitrogen (Cat. # C-10337).
The protocol was modified for whole-mount staining and cryo-sections at 8µm.
Briefly, axolotl embryos were tail amputated and placed in 12-well-plates with 0.1%
DMSO or 10μM Wnt-C59 solution. At 48hpa, embryos were injected peritoneally
with 1ul of 8μM 5-ethynyl-2’-deoxyuridine (EdU). At 72hpa, embryos were
anesthetized and fixed in 4% paraformaldehyde overnight. The samples were
dehydrated and rehydrated using a methanol series (0, 25, 50, 75, 100% in PBS). The
samples were washed 3x with 1% Triton for 5 minutes, then bathed in 2.5% trypsin
for 30 minutes, washed with ice-cold acetone for 10 minutes, followed by PBS and
1% Triton 3x for 5 minutes. Click-iT EdU reaction solution containing 1x Trisbuffered saline, 4mM CuSO4, FAM 488 picolyl azide, and 100mM sodium ascorbate
was used to visualize EdU incorporation into the DNA of proliferating cells. DAPI
was used to stain total nuclear DNA. Cells staining positive for EdU within 400µm of
the tail tip were counted as well as cells staining positive for DAPI within the same
area. A proliferative index was calculated as a ratio of EdU positive cells to DAPI
positive cells. Results were analyzed in GraphPad Prism software version 6.0 (San
Diego California USA) using one-way ANOVA test.

3.4 Results
3.4.1 Blocking Wnt signaling prevents axolotl embryo tail regeneration.
A Porcupine inhibitor, Wnt-C59, was previously demonstrated to inhibit axolotl tail
regeneration using a 10μM dose (Ponomareva et al. 2015). To confirm this result and
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titrate the best dosage, concentrations of Wnt-C59 at 0, 10-4, 10-3, 10-2, 10-1, 1, 2.5, 5,
and 10μM were used to treat developmental stage 42 embryos. The treated embryos
were healthy and active for all treatments tested. Doses of Wnt-C59 above 1μM
inhibited tail regeneration at 168hpa (Figure 3.1, A and B). By varying the time of
Wnt-C59 administration, I detected significant differences in tail length at 7dpa for 012, 12-24, 24-48, 48-72, and 72-120hpa treatments. In contrast, I did not detect a
significant difference in snout-vent length at 168hpa between the DMSO control and
any treatment (Figure 3.1 D). The 120-144hpa group had shorter tails in comparison
to the DMSO controls, but the difference was not statistically significant, presumably
due to the short administration time. The above results indicate a requirement for Wnt
signaling throughout most of the tail regeneration process.
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Figure 3.1 Inhibiting Wnt signaling by Wnt-C59 blocks axolotl tail regeneration. A
and B) Wnt-C59 above 1μM significantly inhibited axolotl embryo tail regeneration.
C) 10µM of Wnt-C59 was administered for different lengths of time, and tail length
was measured. Tail length at 168hpa differed significantly between DMSO control
and Wnt-C59 treatments of 0-12, 12-24, 24-48, 48-72, and 72-120hpa. D) No
significant differences in snout-vent length were detected between Wnt-C59 treated
and DMSO control embryos. *: p-value < 0.05 for contrasts of DMSO control vs
Wnt-C59, n = 4.

3.4.2 Wnt3a is suppressed during tail regeneration.
Previous studies have established that canonical Wnt/β-Catenin signaling promotes
blastema formation and subsequent proliferation in zebrafish fin regeneration (StoickCooper et al. 2007). Wnt3a is a major Wnt ligand mediating Wnt/β-Catenin signaling.
To evaluate if Wnt3a is also expressed during axolotl embryo tail regeneration, Wnt3a
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was detected in pooled tail tips at 24, 48, and 72hpa. In comparison to pre-amputation
levels, Wnt3a expression significantly decreased at 24hpa and 72hpa (Figure 3.2 A
and B, p value < 0.05, n = 3). These data show dynamic changes in Wnt3a expression
during the first 72 hours of tail regeneration.

Figure 3.2 Wnt3a expression decreases during tail regeneration. A) Wnt3a was
detected by western blotting using pooled distal tail tips. β-Actin was blotted as a
loading control. B) Wnt3a was expressed at 0hpa and decreased at 24hpa and 72hpa.
*: p-value < 0.05 for contrasts between 0hpa vs 48hpa or 72hpa, n = 3.

3.4.3 Wnt-C59 increases β-Catenin expression during tail regeneration.
β-Catenin is an important transcription factor that mediates canonical Wnt/β-Catenin
signaling. To investigate β-Catenin expression and determine how Wnt-C59 regulates
β-Catenin levels, I quantified β-Catenin levels in regenerating distal tail tip tissues
that were treated with DMSO or Wnt-C59 at 0, 24, 48, and 72hpa. β-Catenin was
expressed at the time of amputation. Relative to pre-amputation levels, I detected a
significant decrease in β-Catenin expression at 48hpa (Figure 3.2, p < 0.05, n = 3) and
a significant increase in β-Catenin at 72hpa (Figure 3.3, p < 0.01, n = 3). Wnt-C59
increased β-Catenin at 48hpa (Figure 3.3, p < 0.01, n = 3). These results suggest that
canonical Wnt signaling is dynamically changed during tail regeneration and βCatenin increases upon Wnt signaling pathway inhibition.
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Figure 3.3 Wnt-C59 increases β-Catenin expression at 48hpa. A) β-Catenin was
detected by western blotting using Wnt-C59 treated or DMSO control tails. β-Actin
was blotted as a loading control. B) Relative to 0hpa, β-Catenin was significantly
lower at 48hpa and significantly higher at 72hpa. Wnt-C59 increased β-Catenin
expression at 48hpa. *: p-value < 0.05 for contrasts between DMSO control at 0hpa
vs 48hpa or 72hpa, and between DMSO control and Wnt-C59 at 48hpa.

3.4.4. Inhibiting Wnt signaling increases p-Erk and p-Akt expression.
A few studies have shown that Wnt signaling regulates Erk or Akt signaling pathways
(Zhang, Pizzute, and Pei 2014; Bikkavilli and Malbon 2009; Georgopoulos,
Kirkwood, and Southgate 2014). To determine if Wnt signaling affects these
pathways during axolotl tail regeneration, I detected p-Erk and p-Akt using distal
pooled tail tips treated with Wnt-C59 and DMSO at 0, 24, 48, and 72hpa. Both p-Erk
and p-Erk were expressed at the time of amputation but decreased at 24hpa and
increased significantly at 72hpa (Figure 3.4, p < 0.001, n = 3). Wnt-C59 treatment
increased p-Erk at all tested times and increased p-Akt expression at 48hpa and 72hpa
(Figure 3.5, p < 0.001, n = 3). These results suggest that Wnt-C59 up-regulates Erk
and Akt during tail regeneration.
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Figure 3.4 Wnt-C59 increases phosphorylation of Erk at 24, 48, and 72hpa. A) P-Erk
and Erk expression in Wnt-C59 treated and DMSO controls. B) P-Erk was lowly
expressed at 0hpa and 24hpa but increased significantly at 48hpa and 72hpa. Wnt-C59
treatment increased p-Erk expression at 24hpa, 48hpa, and 72hpa. *: p-value < 0.01
for contrasts of DMSO control vs Wnt-C59, n = 3.

Figure 3.5 Wnt-C59 increases phosphorylation of Akt at 48 and 72hpa. A) P-Akt and
Akt expression in Wnt-C59 treated and DMSO controls. B) P-Akt was low at 0hpa. It
significantly decreased at 24hpa and increased at 48hpa and 72hpa in regenerating tail
tips. Wnt-C59 treatment significantly increased p-Akt expression at 48hpa and 72hpa.
*: p value < 0.01 for contrasts of DMSO control vs Wnt-C59, n = 3.

3.4.5 Wnt signaling regulates cell mitosis during axolotl tail regeneration.
To determine if Wnt signaling regulates cell mitosis, a mitotic marker, anti-phosphohistone H3 (Ser10), was used to stain mitotic cells in the tail using whole-mount
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staining. Most of the phospho-histone H3 positive cells were located in the
mesenchyme underlying the epidermis. The mitotic index of the DMSO control
within 400µm of the distal tail tip was 7.5 ± 1.5%. Wnt-C59 treatment reduced the
mitotic index by 2.5 ± 0.6% (Figure 3.6, p < 0.01, n = 3). These results show that Wnt
signaling regulates cell mitosis in the distal tail tip during axolotl tail regeneration.

Figure 3.6 Wnt-C59 inhibits the mitotic index at 48hpa. A) DMSO control tail
stained with phospho-histone H3 in red. The white stippled lines outline medial tail
tissues to the exclusion of tail fins. B) Wnt-C59 treated tail stained with phosphohistone H3. C) Graph comparing the mitotic index in DMSO control and Wnt-C59
treated tails. *: p-value < 0.05 for contrasts of DMSO control vs Wnt-C59.

2.4.6 Wnt signaling regulates cell proliferation during axolotl tail regeneration.
Wnt signaling is required for proliferation of progenitor cells in the blastema during
zebrafish fin regeneration (Stoick-Cooper et al. 2007). To determine whether Wnt
signaling regulates cell proliferation during axolotl tail regeneration, an EdU
incorporation assay was used to detect proliferating cells from 48 to 72hpa. In DMSO
treated samples, proliferating cells were observed in the regenerating tail, especially
within 400μm of the tail tip (Figure 3.7 A-A’’), while Wnt-C59 treatment reduced
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proliferating cells in the tail tip, dorsal fin, ventral fin, and spinal cord (Figure 3.7 BB’’, and D, n = 6, p < 0.001). These data show that Wnt signaling regulates cell
proliferation during tail regeneration. Note that the proliferation index in the spinal
cord of Wnt-C59 treated tails was still very high (44.8% ± 7.6%, n = 6).

Embryos were reared without Wnt-C59 for 33 days to test for a long-term effect of
early Wnt-C59 treatment. Interestingly, a fin-less phenotype was observed, consistent
with a long-term block of fin regeneration. Moreover, Wnt-C59 treated animals did
not develop forelimbs (Figure 3.8). This finding led me to investigate the Wnt
signaling pathway during forelimb bud outgrowth, the results of which are presented
in Chapter 5.
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Figure 3.7 Wnt-C59 reduces cell proliferation. Images A” and B” are cryo-sections of
regenerating tails. All other images are the whole-mount and regenerating tails. A)
DMSO control stained for EdU. A’) DMSO control stained with DAPI. A’’) DMSO
control stained for EdU. B) Tail treated with Wnt-C59 and stained for EdU. B’) Tail
treated with Wnt-C59 and stained with DAPI. B’’) Tail treated with Wnt-C59 and
stained for EdU. C) Wnt-C59 significantly reduced cell proliferation. The
proliferation index for the tail tip and spinal cord was determined from cryo-sections.
For dorsal and ventral fin, proliferating cells were counted in whole-mount samples.
*: p-value < 0.001 for contrasts of DMSO control vs Wnt-C59.
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Figure 3.8 Wnt-C59 blocks dorsal and ventral fin regeneration and forelimb
outgrowth permanently. A) DMSO control with a fully regenerated tail at 33dpa. B)
Amputated tail treated with Wnt-C59 for 7 days and reared to 33 days post tail
amputation. The tail fins were not regenerated and no forelimb was observed.

3.5 Discussion
Wnt signaling pathway is required throughout axolotl tail regeneration.
Wnt signaling is required for many different aspects of tissue regeneration
(Kawakami et al. 2006; Ghosh et al. 2008; Shimokawa et al. 2013; Hamilton, Sun,
and Henry 2016; Yokoyama et al. 2011; Sugiura et al. 2009; Lin and Slack 2008). The
amputated tail is regenerated in 7 days. In this chapter, I blocked Wnt signaling by
varying the time of Wnt-C59 application. I found that Wnt signaling was required
from 0-120hpa, essentially the entirety of axolotl tail regeneration.

β-Catenin and Wnt3a expression during axolotl tail regeneration
β-Catenin is thought to be very important for tissue regeneration because β-Catenin
induces limb regeneration in chick embryos that do not normally regenerate
(Kawakami et al. 2006). β-Catenin is a dual function molecule that coordinates gene
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transcription and also functions in cell-cell adhesion (Giarre, Semenov, and Brown
1998). Cytosolic pools of β-Catenin enter the nucleus and modulate the expression of
specific genes that regulate cell cycle progression (Giarre, Semenov, and Brown
1998). The plasma membrane β-Catenin fraction acts as a component of cell-cell
adhesion interactions that affect cell specification (Giarre, Semenov, and Brown
1998). It is thought that Wnt-induced β-Catenin conformational changes favor
assembly of transcriptional complexes that are key regulators of cell cycle progression
to S phase (Harris and Peifer 2005; Giarre, Semenov, and Brown 1998). Globally
blocking Wnt signaling pathway by Wnt-C59 did not block β-Catenin expression; in
contrast, it increased β-Catenin expression at 48 and 72hpa. It has been shown that
Wolffian lens regeneration in newt requires Wnt/β-Catenin signaling (Hayashi et al.
2006), but Hamilton et al (2016) found that activation of Wnt signaling impairs
cornea-lens regeneration which requires suppression of Wnt/β-Catenin signaling.
These findings suggest that the requirement for Wnt/β-Catenin signaling depends on
tissue type and mode of regeneration.

I found that tail amputation decreased β-Catenin expression at 24hpa and 48hpa and
increased β-Catenin at 72hpa. This suggests that β-Catenin levels are dynamically
regulated during axolotl tail regeneration. This finding is consistent with a recent
study that showed inhibition of tail regeneration using Wnt agonist II SKL, a
compound thought to increase β-Catenin expression (Ponomareva et al. 2015).
Moreover, Wnt agonist treatment before blastema formation inhibited Xenopus limb
regeneration through inhibiting innervation, while treatment after blastema formation
caused disorganization of skeletal features (Wischin et al. 2017). Amputated limbs
treated with Wnt agonist at the onset of Xenopus limb regeneration did not form a
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blastema (Wischin et al. 2017). It is also supported by similar findings in studies of
Xenopus forelimb regeneration, where down-regulation of Wnt/β-Catenin signaling
did not prevent limb regeneration (Yokoyama et al. 2011; Hamilton, Sun, and Henry
2016). Furthermore, I found that Wnt3a was decreased at 24 and 72hpa, which further
supports the idea that β-Catenin levels dynamically change upon tail amputation, and
these changes are essential for successful tail regeneration.

Upregulation of β-Catenin is associated with upregulation of Erk and Akt
signaling in Wnt-C59 treated tails.
In this study, I found that p-Erk and p-Akt were down-regulated at 24hpa but
increased at 72hpa in regenerating tails. P-Erk levels were up-regulated by Wnt-C59
at 24, 48 and 72hpa. P-Akt levels were upregulated by Wnt-C59 at 48 and 72hpa.
High β-Catenin levels associated with high p-Akt and p-Erk levels in Wnt-C59 treated
tails. Wnt signaling is known to affect Erk and/or Akt signaling in other models
(Zhang, Pizzute, and Pei 2014). There is a positive feedback loop between Wnt and
Erk pathways in which Erk activation upregulates β-Catenin through inactivation of
Gsk-3β, and β-Catenin activates Raf1 through unknown mechanisms to activate Erk
(Ding et al. 2005; Kim et al. 2007; Georgopoulos, Kirkwood, and Southgate 2014).
While I observed similar changes in β-Catenin, p-Akt, and p-Erk, it remains to be
shown how Wnt-C59-induced changes in the levels of these signaling molecules
block axolotl tail regeneration.
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Disruption of Wnt signaling differentially affects cell mitosis in proximal and
distal regions of the tail.
Broadly blocking Wnt signaling by Wnt-C59 reduced both cell mitosis and cell
proliferation within 400μm of the distal tail tip. Thus, Wnt-C59 may inhibit tail
regeneration by blocking cell proliferation that is necessary to reform tissues, which
suggests that Wnts act as mitogens to control cell proliferation in the tail tip during
axolotl tail regeneration. Interestingly, while I found that Wnt-C59 affected cell
proliferation in medial and tail fin tissues, only the tail fin was permanently inhibited
after discontinuation of Wnt-C59 treatment. Thus, Wnt-C59 provides a valuable new
tool for regenerative biology because it can be used to decouple regeneration
processes and investigate tissue-level differences in the requirement for Wnt
signaling. In the absence of Wnt signaling during regeneration, progenitor cells in the
tail fin mesenchyme are seemingly depleted, perhaps through mechanisms of cell
death, quiescence, or differentiation. This hypothesis awaits further study.

In summary, this study demonstrates the requirement of Wnt signaling during tail
regeneration. Wnt inhibitor Wnt-C59 upregulated β-Catenin, p-Akt and p-Erk, and
these changes were associated with a reduction in cell proliferation and mitosis of the
regenerating tail tip. My findings suggest that temporal regulation of Wnt/β-Catenin is
required for successful axolotl tail regeneration.
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4.1 Abstract
Fgf signaling plays an essential role during amphibian appendage regeneration, but its
function during axolotl embryo tail regeneration is unknown. Here I used an Fgf
receptor inhibitor (BGJ398) to disrupt Fgf signaling during axolotl tail regeneration.
Concentrations of BGJ398 above 1μM inhibited tail regeneration. By varying the time
of delivery of BGJ398, I found that Fgf signaling is critical during the first 12 hours
of tail regeneration. Inhibition of Fgf signaling affected multiple molecular and
cellular level processes during tail regeneration, including phosphorylation of Erk and
Akt, Wnt3a/β-Catenin signaling, cell proliferation, and cell mitosis. The effect of
BGJ398 was reversible as embryos that were initially treated with BGJ398 and then
washed out fully regenerated their tails. These results show that Fgf signaling is
required for axolotl tail regeneration.

4.2 Introduction
An axolotl embryo tail regeneration model was recently established to investigate
signaling pathway mechanisms associated with tissue regeneration. Ponomareva et al.
(2015) showed a requirement for Fgf signaling during tail regeneration by blocking
Fgf-receptor function with a small molecule (BGJ398). Also, in that study, chemical
inhibition of Wnt-ligand secretion using Wnt-C59 decreased transcription of
fibroblast growth factor 9 (Fgf9). These results suggest that Fgf signaling is
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downstream of Wnt signaling, as has been reported in other tissue regeneration
models (Lin and Slack 2008; Love et al. 2013). In this chapter, I describe experiments
that were performed to more rigorously establish that Fgf signaling is required for tail
regeneration.

Fgf signaling pathway plays roles in cell proliferation, mitogenesis, differentiation,
angiogenesis, and embryogenesis (Ornitz and Marie 2015). There are 22 Fgf ligands
grouped into seven subfamilies and four Fgf receptors (Fgfrs) in vertebrates (Dorey
and Amaya 2010). Fgf signaling is initiated by binding of Fgf ligands to Fgfrs. A
ligand-dependent dimerization event leads to the formation of a complex consisting of
two Fgfs, two heparin sulfate chains, and two Fgfrs (Plotnikov et al. 1999). Each
ligand binds to two receptors contacted with each other via a D2 domain, which
results in the trans-phosphorylation of each receptor monomer (Schlessinger 2000).
Upon the binding of Fgf ligands to receptors, the tyrosine residues on the docking
protein Frs2-alpha are phosphorylated (Hadari et al. 2001). Two downstream
pathways associated with Fgf signaling pathway are the Ras/Map kinase pathway and
the PI3/Akt pathway (Armstrong et al. 2006). The Ras/Map kinase pathway is
associated with many biological processes, including cellular proliferation and
differentiation (Shapiro 2002). Map kinase effectors include Erk, c-Jun N-terminal
kinase (Jnk), and p38 mitogen-activated kinase (Cargnello and Roux 2011). The
PI3k/Akt pathway is also associated with many biological processes, including cell
survival and cell fate determination (Yu and Cui 2016).

Several Fgf ligands have been shown to play key roles in tissue regeneration. Fgf
signaling factors are considered neurotrophic factors because they are expressed in
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nerve tissue during axolotl limb regeneration and promote blastema formation and
outgrowth (Mullen et al. 1996; Satoh et al. 2011). Fgf8 is expressed in the basal layer
of the AEC during blastema formation, and Fgf8 and Fgf10 are upregulated in
underlying mesenchymal cells. Fgf8 is expressed in the anterior mesenchyme and its
expression depends on sonic Hedgehog (Shh) signaling from posterior tissue during
axolotl limb regeneration. Ectopic Fgf8 and endogenous Hh signaling are sufficient to
induce axolotl limb regeneration from cells of a posterior blastema (Nacu et al. 2016).
Consistent with the idea that Fgfs are neurotrophic factors, denervation of the limb
prevents Fgf8 and Fgf10 upregulation during axolotl limb regeneration (Kolodziej et
al. 2001; Han et al. 2001). Fgf2 and Fgf8, together with growth and differentiation
factor-5 (Gdf5), are sufficient to substitute nerve induction of limb and tail
regeneration in urodele amphibians (Makanae et al. 2013).

In this study, I examined Fgf signaling pathway components during axolotl tail
regeneration. Disruption of Fgf signaling by BGJ398 inhibited tail regeneration.
Interestingly, BGJ398 treatment upregulated both Wnt3a and β-Catenin. Under the
assumption that Fgf signaling is regulated by Wnt signaling, this suggests that Fgf
signaling activity regulates Wnt ligand expression. BGJ398 treatment also
downregulated Erk signaling, upregulated Akt signaling, and reduced cell
proliferation and mitosis.

4.3 Methods
4.3.1 Regeneration experiments
Axolotl embryos were reared at 16°C in 40% Holtfreter’s solution. Embryos at
developmental stage 42 (Bordzilovskaya & Dettlaff, 1989) were used for all the tail
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regeneration experiments (Ponomareva et al. 2015). BGJ398 (Selleckchem, Cat.
#S2183) was dissolved in DMSO to make a 10mM stock solution and then diluted
further to make 10μM working solutions. DMSO at 0.1% was used for controls.
Axolotl embryos were dechorionated and anesthetized in 0.02% benzocaine, and 2mm
of the distal tail tip was amputated using a sterile blade. Embryos were reared singly,
one per well, in 12-well microtiter plates for the timing experiments and
immunofluorescence (IF) staining. Five embryos were reared per well for tissue
collection to perform Western blotting experiments. There were 7 groups in the
timing experiment: 0.1% DMSO control, and 10μM Wnt-C59 administered from 012, 12-24, 24-48, 48-72, 72-120, and 120-144hpa. The embryos were photographed at
different post-amputation times. Tail length and snout-vent length were measured
from the images. Statistical analyses were performed using GraphPad Prism software
version 6.0 using Student’s t-test.

4.3.2 Antibodies
Anti-Erk (Cat. #4348), Anti-phospho-Erk (Thr202/Tyr204) (Cat. #4370), Anti-Akt
(Cat. #9272), Anti-phospho-Akt (Ser473) (Cat. #9271), and Anti-β-Catenin (Cat. #
610154) were purchased from BD Biosciences. Anti-Wnt3a (Cat. # bs-1700R) was
obtained from Bioss Antibodies. Anti-β-actin (Cat. #5125S) was purchased from Cell
Signaling Technology. Anti-phospho-Histone H3 (Ser10) (Cat. # 05-1336) was
purchased from Millipore. Goat anti-Rabbit IgG, (H+L) HRP conjugate (Cat. #
AP307P) and Goat anti-Mouse IgG, (H+L) HRP-conjugated secondary antibodies
(Cat. #AP308P) were purchased from Millipore. Cy3™ AffiniPure Donkey AntiMouse IgG (H+L) (Cat. #715-165-151) was purchased from Jackson Immune
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Research. DAPI (4', 6-diamidino-2-phenylindole, dihydrochloride, Cat. #62247) was
purchased from Thermo Scientific.

4.3.3 Tissue processing and immunochemistry staining
An existing protocol was modified for cryosection immunostaining (Qiu et al. 2015).
In brief, samples were fixed in 4% paraformaldehyde (PFA) overnight. Samples were
dehydrated through a methanol series, starting in 100% PBS and then 25, 50, 75, and
100% methanol. These samples were saved at -20ºC for later use. The samples were
rehydrated for whole-mount staining or OCT embedding. After OCT embedding,
8μM sections were prepared for staining or saved at -80°C for later use. Primary Antiphospho-Histone H3 (Ser10) was used at 1:1000, and the secondary Cy3™ AffiniPure
Donkey Anti-Mouse IgG (H+L) was used at 1:200. Blocking solution was modified
as 5% sheep serum. Total DNA was labeled by DAPI. Stained slides were imaged
using a confocal microscope (Nikon Tie and C2+ Confocal). A mitotic index was
determined by dividing the number of histone H3 positive cells by the number of
DAPI positive cells within 200μm. Statistical analysis was performed using GraphPad
Prism software version 6.0 using Student’s t-test.

4.3.4 Western blotting
Embryos were anesthetized with 0.02% benzocaine and then 1mm of the distal tail tip
was cut using a sterile blade. Tail tips of 30 embryos were pooled for each sample.
The pooled tail tips were washed 2x using 1x PBS solution with
proteinase/phosphatase inhibitor mixture (#5872S, Cell Signaling Technology), and
then tissue was lysed in RIPA buffer (#R0278, Sigma) with proteinase/phosphatase
inhibitor mixture by using a 22.5-gauge-needle and 1 ml syringe. Protein
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concentrations were determined by a BCA protein assay (#23225, Thermo Scientific).
Equal amounts of tissue lysate were loaded into lanes of 10% SDS polyacrylamide
gels and transferred to a PVDF membrane. The membranes were blotted with 5%
non-fat milk and then incubated overnight at 4°C with primary antibodies. After this,
membranes were treated with HRP-conjugated secondary antibodies. The immune
complexes were detected by enhanced chemiluminescence (Cat# NEL103001,
PerkinElmer). Quantification of band intensities was performed using ImageJ
software (http://rsbweb.nih.gov/ij/). Statistical analyses were performed using
GraphPad Prism software version 6.0 using Student’s t-test.

4.3.5 EdU cell proliferation assay
An EdU cell proliferation assay was performed using FAM picolyl azide from Click
Chemistry Tools (Cat. # 1180-1), along with CuSO4 and sodium ascorbate in the
Click-iTTM EdU Alexa FluorTM 488 Imaging Kit from Invitrogen (Cat. # C-10337).
The protocol was modified for whole-mount staining and cryo-sections at 8μm.
Briefly, axolotl embryos were tail amputated and placed in 12-well-plates with 0.1%
DMSO or 10μM BGJ398 solution. At 48hpa, embryos were injected peritoneally with
1ul of 8μM 5-ethynyl-2’-deoxyuridine (EdU). At 72hpa, embryos were anesthetized
with 0.02% benzocaine and fixed in 4% paraformaldehyde overnight. The samples
were dehydrated and rehydrated using a methanol series (0, 25, 50, 75, 100% in PBS).
The samples were washed 3x with 1% Triton for 5 minutes, then bathed in 2.5%
trypsin for 30 minutes, washed with ice-cold acetone for 10 minutes, followed by PBS
and 1% Triton 3x for 5 minutes. Click-iT EdU reaction solution containing 1x Trisbuffered saline, 4mM CuSO4, FAM 488 picolyl azide, and 100mM sodium ascorbate
was used to visualize EdU incorporation into the DNA of proliferating cells. DAPI
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was used to counter stain the samples. Cells staining positive for EdU within 400μm
of the tail tip were counted as well as cells staining positive for DAPI within the same
area. A proliferative index was calculated as the ratio of EdU positive cells to DAPI
positive cells. Results were analyzed in GraphPad Prism software version 6.0 (San
Diego California USA) using one-way ANOVA.

4.4 Results
4.4.1 Blocking Fgf signaling inhibits axolotl embryo tail regeneration.
BGJ398, a potent inhibitor of Fgf signaling, was previously shown to inhibit axolotl
tail regeneration in a chemical genetic screen (Ponomareva et al. 2015). Here I more
rigorously investigated timing and dosage of BGJ398 during axolotl tail regeneration.
Concentrations of BGJ398 at 0, 10-4, 10-3, 10-2, 10-1, 1, 2.5, 5, and 10µM were used to
treat developmental stage 42 axolotl embryos. The treated embryos were healthy and
active within all treatment groups. Concentrations of BGJ398 above 1μM
significantly inhibited tail regeneration at 7 days post tail amputation (dpa). By
varying the time of BGJ398 administration, I detected a significant difference in tail
length at 7dpa for the 0-12hpa treatment group compared with DMSO controls.
Interestingly, I observed cup-shaped tails that folded anteriorly in 1, 2.5, and 5µM
BGJ398 treated tails, a phenotype described by Voss et al. (2019) (Figure 4.1 A).
These results establish that Fgf signaling is required for tail regeneration and the
critical time for Fgf signaling is 0-12hpa.

72

Figure 4.1 Blocking Fgf receptors prevents axolotl embryo tail regeneration. A) and
B) BGJ398 above 1μM significantly inhibited axolotl embryo tail regeneration. C)
10μM of BGJ398 was administered for different periods, and the tail length was
measured. Tail length at 7dpa differed significantly between DMSO control and the 012hpa BGJ398 treatment. D) No significant difference in snout-vent length was
detected between BGJ398 treated and DMSO control embryos. *: p-value < 0.05 for
contrasts of DMSO control vs Wnt-C59.

4.4.2 BGJ398 downregulates phosphorylation of Erk.
Upon Fgf ligand binding, Fgfr activates downstream signaling cascades, including the
Mapk/Erk signaling pathway (Mukerjee 1947). To determine if Fgf/Erk signaling is
activated during axolotl tail regeneration, I quantified phosphorylated Erk (p-Erk)
expression by Western blotting. In DMSO control embryos, p-Erk was detected at the
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time of amputation and increased at 24hpa (Figure 4.2, p-value < 0.001, n = 3). After
this time, p-Erk levels at 48hpa (Figure 4.2, p-value < 0.05, n = 3), but not 72hpa
(Figure 4.2, p-value > 0.05, n = 3), were significantly higher than basal (day0) levels.
A similar pattern of expression was observed for embryos treated with continuous
BGJ398 treatment. However, the spike in p-Erk at 24hpa was significantly lower than
that observed in controls (Figure 4.2, p-value < 0.01, n = 3). These results show that
inhibition of Fgf signaling reduces p-Erk at 24hpa.

Figure 4.2 BGJ398 decreases phosphorylation of Erk at 24hpa. A) P-Erk and Erk
were detected by Western blotting using pooled 1mm tail tips from BGJ398 treated or
DMSO control embryos at 0, 24, 48, and 72hpa. B) P-Erk expression was normalized
against Erk. *: p-value < 0.01 for contrast of DMSO control vs BGJ398.

4.4.3 BGJ398 upregulates phosphorylation of Akt.
Activated Fgf receptors also regulate the Akt pathway, which promotes cell survival
and growth (Yu and Cui 2016). To determine if Fgf/Akt signaling is activated during
axolotl tail regeneration, I quantified phosphorylated Akt (p-Akt) expression. In
DMSO control embryos, p-Akt was detected at the time of amputation and decreased
at 24hpa (Figure 4.3, p = 0.053, n = 3). Between 24-48hpa, p-Akt levels increased,
roughly approximating basal levels. After this time, levels decreased at 72hpa. This
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complex temporal pattern was also observed in embryos treated continuously with
BGJ398. However, p-Akt levels were significantly higher in BGJ398 treated embryos
than controls at 48hpa and 72hpa (Figure 4.3, p-value < 0.05, n = 3). These results
show that Akt phosphorylation is dynamically regulated during tail regeneration and
inhibition of Fgf signaling increases p-Akt at 48 and 72hpa.

Figure 4.3 BGJ398 downregulates phosphorylation of Akt. A) P-Akt and Akt were
detected by Western blotting using pooled 1mm tail tips from BGJ398 treated or
DMSO control embryos at 0, 24, 48, and 72hpa. B) P-Akt expressions were
normalized against Akt. *: p-value < 0.05 for contrast of DMSO control vs BGJ398.

4.4.4 BGJ398 upregulates Wnt/β-Catenin signaling.
The Wnt/β-Catenin and Fgf signaling pathways are required for zebrafish fin
regeneration and Xenopus limb regeneration, and in both cases, Wnt/β-Catenin
signaling acts upstream of Fgf signaling (Poss et al. 2000; Yokoyama et al. 2007;
Stoick-Cooper et al. 2007). To test if Fgf signaling affects Wnt/β-Catenin signaling
during tail regeneration, Wnt3a and β-Catenin were detected by western blotting.
Wnt3a was detected at the time of tail amputation, decreased at 24hpa, and
approximated basal (day0) levels at 48 and 72hpa (Figure 4.6, p-value < 0.05, n = 3).
β-Catenin was also expressed at the time of tail amputation and increased at 72hpa
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(Figure 4.6, p-value < 0.05, n = 3). Continuous BGJ398 treatment increased Wnt3a at
48 and 72hpa, and increased β-Catenin at 48hpa (Figure 4.6, p-value < 0.05, n = 3).
These data show that BGJ398 inhibition of Fgf signaling increases the expression of
Wnt ligands.

Figure 4.4 BGJ398 upregulates Wnt ligand expression. A) Wnt3a, β-Catenin, and βActin were detected by Western blotting using pooled 1mm tail tips from BGJ398
treated or DMSO control embryos at 0, 24, 48, and 72hpa. B) Wnt3a expression was
normalized against total β-Actin. BGJ398 increased Wnt3a expression at 48hpa and
72hpa. B) β-Catenin expression was normalized against β-Actin. BGJ398 increased βCatenin expression significantly at 48hpa. *: p-value < 0.05 for contrast of DMSO
control vs BGJ398.

4.4.5 Fgf signaling regulates cell mitosis during axolotl tail regeneration.
Fgf signaling sustains progenitor cell mitogenic activity during zebrafish fin
regeneration and muscle regeneration (Shibata et al. 2016; Saera-Vila, Kish, and
Kahana 2016). To determine if Fgf signaling is similarly needed to sustain mitogenic
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activity during axolotl tail regeneration, anti-phospho-histone H3 (Ser10) staining was
performed to identify mitotic cells at 48hpa. Approximately twice (7.5± 1.5%) as
many mitotic cells were observed in DMSO control versus BGJ398-treated embryos
(Figure 4.5, p < 0.05, n = 3). These results suggest that Fgf signaling is required to
sustain cell mitosis during axolotl tail regeneration.

Figure 4.5 BGJ398 inhibits mitosis in axolotl tails at 48hpa. A) DMSO control tail
stained with phospho-histone H3. The white stippled lines outlined the tail. The other
tissues are fins. B) BGJ398 treated tail stained with phospho-histone H3. C) Graph
comparing the mitotic index in DMSO control and BGJ398 treated tails (n = 3
embryos). *: p-value < 0.05 for contrast of DMSO control vs BGJ398.

4.4.6 BGJ398 reduces the number of cells in S-phase.
Fgf signaling is required for cell proliferation of blastema cells during zebrafish tail
regeneration (Shibata et al. 2016). To determine if Fgf signaling regulates cell
proliferation during axolotl tail regeneration, an EdU incorporation assay was used to
detect S-phase cells at 72hpa. BGJ398 treatment reduced proliferating cells in the tail
tips, dorsal fins, and ventral fins (Figure 4.6, p < 0.001, n = 6), but not the spinal cord
(Figure 4.6, p > 0.05, n = 6). These results suggest that Fgf signaling regulates cell
proliferation in the tail tip and fins during axolotl tail regeneration.
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Figure 4.6 BGJ398 reduces S-phase entry of cells in the tail but not the spinal cord.
Image A’’ and B’’ are cryo-sections of regenerating tails. Images in panels C-D are
whole-mounts. A) DMSO control stained with EdU A’) DMSO control stained with
DAPI A’’) DMSO control stained with EdU and DAPI. B) Tail treated with BGJ398
and stained with EdU. B’) Tail treated with BGJ398 and stained with DAPI. B’’) Tail
treated with BGJ398 and stained with EdU and DAPI. C) The proliferative index for
tail tissues was estimated from counted cells in cryo-sections due to the thickness of
the tail. For dorsal and ventral fins, cells were counted in whole-mount preparations.
BGJ398 reduced cell proliferation of the tail except for the spinal cord. D) An image
with labeled tissue types. E) Full tail regeneration at 12dpa of an embryo treated for 7
days with BGJ398. *: p-value < 0.05 for contrast of DMSO control vs BGJ398.

4.5 Discussion
The results in this chapter show that Fgf signaling pathway is required for axolotl tail
regeneration. Embryos that were treated with BGJ398, a small molecule inhibitor of
Fgf signaling did not regenerate their tail. In addition to blocking tail regeneration,
BGJ398 reduced p-Erk levels at 24hpa and increased p-Akt at 48hpa and 72hpa.
These pathways are known to regulate many biological processes, including cell
division and growth, and embryos treated with BGJ398 presented fewer S-phase and
mitotic phase cells, consistent with inhibition of cell proliferation.

Fgf signaling inhibitor BGJ398 acts during the first 12 hours of tail regeneration.
By varying the time that BGJ398 was administered to embryos, I identified a 12hr
post-amputation window of time within which Fgf signaling is required for successful
tail regeneration. This was an unexpected finding because Fgf signaling is thought to
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be activated downstream of Wnt signaling, which is activated after this time. For
example, I showed in Chapter 3 that Wnt ligands were not up-regulated until at least
48hpa, and in Ponamareva et al (2015), Wnt pathway target genes were not
differentially expressed between Wnt-C59 treated and control axolotl embryos until
24 hpa. Thus, it seems likely that Fgf signaling is regulated independently of Wnt
signaling, at least during the first 12 hours of regeneration. It is tempting to think that
during this interval of time, Fgf signaling is required for proper formation of the
wound epithelium, as is known for zebrafish fin regeneration (Whitehead et al. 2005).
Studies of axolotl limb regeneration have shown that the basal layer of the wound
epithelium, and underlying mesenchymal cells, secrete Fgf ligands that support
progenitor cell proliferation (Mullen et al. 1996; Satoh et al. 2011). Perhaps, if the
wound epithelium does not develop competence for Fgf ligand secretion during the
first 12 hours of regeneration, activated progenitor cells are stalled in the cell cycle
until the Fgf signaling block is released. After 12 hours, progenitor cell proliferation
may no longer depend upon Fgf signaling. In other words, cells gain autonomy for
cell proliferation after 12hpa, in much the same way that progenitor cells of
regenerating limbs escape nerve-dependency at later stages of blastema maturation
(Kumar et al. 2007; McCusker, Bryant, and Gardiner 2015). This hypothesis is
consistent with the results of this study, including the reversibility of BGJ398
inhibition of Fgf signaling.

Erk and Akt signaling pathways during axolotl tail regeneration
In control embryos, Erk phosphorylation was significantly increased at 24hpa and
high levels were sustained at 48hpa and 72hpa. BGJ398 treatment significantly
decreased Erk phosphorylation at 24hpa. Erk phosphorylation is required for re-entry
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of post-mitotic newt muscle cells by downregulation of P53 activity, while only
transient Erk activation is observed in mammalian counterparts (Yun, Gates, and
Brockes 2014). Although muscle de-differentiation and cell cycle entry do not occur
in axolotls, differential changes in Erk signaling may be associated with cell cycle
regulation. Indeed, fewer M-phase and S-phase cells were observed in BGJ398 treated
embryos. Akt phosphorylation was decreased at 24hpa in DMSO control embryos and
BGJ398 treatment increased Akt phosphorylation at 48 and 72hpa. Since the PI3k/Akt
pathway plays a role in cell fate determination (Yu and Cui 2016), suppression of Akt
phosphorylation during regeneration, as was observed in control embryos, may
sustain progenitor cell proliferation. This hypothesis awaits further study.

BGJ398 upregulates Wnt/β-Catenin signaling pathway.
Inhibition of Fgf signaling by BGJ398 was associated with a significant increase in
Wnt3a and β-Catenin expression at 48 and 72hpa. This suggests that regulation of
Wnt/β-Catenin signaling may depend upon the activity state of the Fgf pathway.
When Fgf signaling activity is dampened, β-Catenin mediated signaling increases to
return Fgf signaling to basal levels under homeostatic conditions, or levels needed to
support proliferating cells during tail regeneration. Such a model is consistent with the
hierarchical regulation of Fgf signaling by canonical Wnt signaling during later
phases of regeneration when cell proliferation and tail outgrowth are maximal. My
results enrich this model by implicating a feedback mechanism between these two
pathways. However, Fgfr1 antagonist SU-5402 decreased Wnt3a expression during
Xenopus tail regeneration (Lin and Slack 2008). This may reflect a species-specific
difference between axolotls and Xenopus, a difference in the action of Fgf inhibitors
between studies, or a limitation of feed-back regulation to β-Catenin-mediated Wnt
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signaling in Xenopus. Overall, my results suggest that Fgf and Wnt signaling
pathways interact to regulate cell proliferation during axolotl tail regeneration.
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5.1 Abstract
Wnt signaling pathway and Fgf signaling pathway are key regulators of limb
development in vertebrates such as chicken and mice. How Wnt and Fgf signaling
pathways regulate forelimb bud outgrowth in the axolotl (Ambystoma mexicanum) is
unknown. Here I demonstrate that Wnt signaling is required for forelimb bud
development in the Mexican axolotl. Inhibiting Wnt signaling by Wnt-C59 prevented
forelimb bud development. The critical window for inhibition was approximately
developmental stage 40-42. Expression of canonical Wnt signaling ligand Wnt3a and
cell polarity marker Zo1 were significantly decreased in epidermal cells of the
forelimb bud in Wnt-C59 treated forelimbs. Moreover, Wnt-C59 treatment appeared
to disrupt the orientation and density of mesodermal cells in the forelimb bud and
significantly decreased mesodermal cell proliferation and mitosis. The results of this
study indicate a requirement for Wnt signaling during forelimb bud development in
the axolotl.

5.2 Introduction
Vertebrate limb development is a classic model for investigating patterning of threedimensional structures during organ embryogenesis (Towers and Tickle 2009; Yang
2003). Three axes are used to characterize limb structure: a proximal-distal axis (P-D
axis) runs along the arm from shoulder to digits; an anterior-posterior axis (A-P axis),
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runs from the thumb to the little finger; and a dorsal-ventral axis (D-V axis), runs
from the back of the hand to the palm. Three major signaling centers direct limb
development along these axes. The first signaling center to appear during limb
development is the apical ectodermal ridge (AER), which forms as a thickened
epithelial cell layer at the distal part of the early limb bud. Fibroblast growth factors
(Fgfs) in the AER are sufficient and necessary for AER function in proximal-distal
limb outgrowth and patterning (Mariani, Ahn, and Martin 2008; Saunders 1998;
Niswander and Martin 1993). The second signaling center is the zone of polarizing
activity (ZPA). Sonic Hedgehog (Shh) signaling from the ZPA regulates anteriorposterior patterning (Ogura et al. 1996). The third signaling center is the non-AER
limb ectoderm. The limb ectoderm produces molecules which are essential for dorsal
( e.g., Wnt7a: (Riddle et al. 1995) and ventral (e.g., Engrailed-1: (Loomis et al. 1996)
patterning. Signaling from the AER, ZPA, and limb ectoderm are crucial for the
formation of a limb with correct axial polarity (Tickle 2015).

Several signaling pathways (such as the Wnt signaling pathway, Fgf signaling
pathway, retinoid acid signaling pathway, and Bmp signaling pathway) and
transcription factors (Tbx4, Tbx5, Pitx1, Nf-kappaB, Hoxb13, and Hoxc10) have been
associated with limb patterning (Carlson et al. 2001; Bushdid et al. 1998; Kanegae et
al. 1998; Grandel and Brand 2011; Kawakami et al. 2001; Christen et al. 2012; Duboc
and Logan 2011). These signaling pathways must be tightly regulated spatially and
temporally to ensure limb bud outgrowth. A hallmark of early vertebrate limb
development is the limb bud. Limb bud outgrowth depends on signaling from the
AER (Hamburger and Hamilton 1992). A regulatory loop consisting of Wnt factors
Wnt3a, Wnt2b and Wnt8c, and fibroblast growth factors Fgf8 and Fgf10, play a key
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role in both AER induction and limb bud outgrowth (Kawakami et al. 2001). Wnt3a is
the earliest known AER marker during chick limb development. It signals through the
canonical β-Catenin pathway and mediates Fgf10 to induce Fgf8 expression in the
limb ectoderm during AER formation in the chick (Kengaku et al. 1998; Kawakami et
al. 2001). It is thought that the limb bud is defined by a temporal succession of
signaling events. For example, Christen et al. (2012) demonstrated that retinoic acid
from somites specifies the limb field by activating Wnt ligands (wnt2b in forelimb
and wnt8c in hindlimb) in the intermediate mesoderm, which is followed by the
expression of tbx5 and tbx4 in the lateral plate mesoderm at positions where fore- and
hind limb develop, respectively. Fgf10 signaling from the mesoderm to the overlaying
ectoderm then induces the formation of the apical epidermal ridge, thereby
establishing a signaling center for proximal-distal limb outgrowth (Christen et al.
2012). These data suggest that Wnt signaling plays an essential during early limb
development.

The “proliferation gradient” model has been the most prominent hypothesis of
physical morphogenesis of limb bud outgrowth, first proposed by Ede and Law (Ede
and Law 1969). They proposed that a mitogen released by the AER signals underlying
mesodermal cells to proliferate and form a P-D progress or proliferation zone (Reiter
and Solursh 1982). There is another hypothesis explaining limb bud morphogenesis:
oriented cell divisions, which has been found during limb bud extension (Wyngaarden
et al. 2010). To achieve uniform polarity, mesodermal cells of the limb bud must
employ a mechanism establishing and coordinating polarized cell behaviors along
their developmental axes (Gao and Yang 2013). Wnt5a signaling gradients establish
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planar cell polarity in chondrocytes along the P-D axis via Vangl2 phosphorylation
(Gao and Yang 2013).

Although many studies have shown the importance of Wnt signaling during vertebrate
limb development, little is known about Wnt signaling during forelimb bud
development in the axolotl. In this study, a Porcupine inhibitor, Wnt-C59, was used to
show a requirement for Wnt signaling during forelimb bud development in the
axolotl.

5.3 Methods
5.3.1 Animal husbandry and timing experiments for limb bud outgrowth.
Axolotl embryos were reared at 16°C in 40% Holtfreter’s solution. Embryos at
developmental stage 40 (Bordzilovskaya & Dettlaff, 1989) were used for all
experiments. Wnt-C59 (Selleckchem, Cat. #S7030) was dissolved in DMSO to make
a 10mM as stock solution and then diluted further to make 10μM working solutions
(DaCosta Byfield et al. 2004). NVP-BGJ398 (Selleckchem, Cat. #S2183) was
dissolved in DMSO at 10mM and then diluted to 10μM for regeneration experiments
(Denis et al. 2016). DMSO at 0.1% was used as a control. Axolotl embryos were
dechorionated one day before the embryos reached developmental stage 40. In the
timing experiment for limb bud outgrowth, a total of 155 axolotls were divided into
30 treatment groups plus one 0.1% DMSO control group. Each Wnt-C59 treated
group was treated for three days, thus providing an overlapping series of treatments
throughout the time course of forelimb development (Figure 5.1). The axolotls were
anesthetized in 0.02% benzocaine and photographed 33 days after developmental
stage 40. A few controls and Wnt-C59 treated animals (Day1-3 treatment group) were
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reared to approximately one year of age. At this time, they were anesthetized and then
photographed. Three aurora kinase inhibitors, CYC116, MK-5108, and Danusertib at
10mM in DMSO solution were obtained from Dr. Jon Thorson’s Lab and were diluted
further to make 10μM working solutions. The stage 40 embryos were treated
separately with the three aurora kinase inhibitors for 7 days, and then washed out and
reared for another 7 days, at which time they were photographed.

5.3.2 Antibodies
Rabbit anti-Wnt3a antibodies were obtained from bioss (Cat. # bs-1700R). Rabbit
anti-Zo1 (Cat. #61-7300) was purchased from Invitrogen. Anti-phospho-Histone H3
(Ser10) (Cat. # 05-1336) was purchased from Millipore. Cy3™ AffiniPure Donkey
Anti-Mouse IgG (H+L) (Cat. #715-165-151) was purchased from Jackson immune
Research. DAPI (4', 6-diamidino-2-phenylindole, dihydrochloride, Cat. #62247) was
purchased from Thermo Scientific.

5.3.3 H& E staining and immunochemistry staining
An existing protocol was modified for immunostaining (Qiu et al. 2015). In brief,
samples were fixed in 4% paraformaldehyde (PFA) overnight. Samples were
dehydrated through a methanol series, starting in 100% PBS and move up through 25,
50, 75, and 100% methanol. These samples were used freshly or saved at -20ºC for
later use. Samples were rehydrated for whole-mount staining or OCT embedding.
After OCT embedding, 8μM sections were prepared at D-V/P-D plane or A-P/P-D
plane of forelimb bud for staining or saving at -80°C for later use. For H&E staining,
sections were stained using filtered hematoxylin (VWR, # 95057-844) and 0.5%
Eosin and mounted with Permount (Fisher Chemical, #. SP15-100). For
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immunochemistry staining, epitope retrieval was done by heating in 10mM Tris-HCl
solution (pH 9.5) on a hot plate. Primary Anti-phospho-Histone H3 (Ser10) antibodies
were used at 1:1000. Anti-Zo1 and anti-Wnt3a antibodies were used at 1:100. The
secondary Cy3™ AffiniPure Donkey Anti-Mouse IgG (H+L) antibodies were used at
1:200. Blocking solution was modified into 5% sheep serum. Total DNA was labeled
by DAPI. Stained slides were imaged using a confocal microscope (Nikon Tie and
C2+ Confocal). A mitotic index was determined by dividing the number of histone
H3 positive mesodermal cells by the number of DAPI positive mesodermal cells
within the limb bud. Results were analyzed in GraphPad Prism software version 6.0
using Student’s t-test.

5.3.4 EdU cell proliferation assay
An EdU cell proliferation assay was performed using FAM Picolyl Azide from Click
Chemistry tools (Cat. # 1180-1), and CuSO4 and Sodium Ascorbate in the Click-iTTM
Edu Alexa FluorTM 488 Imaging Kit (Invitrogen, Cat. # C-10337). The protocol was
modified for whole-mount 5-ethynyl-2’-deoxyuridine (EdU) staining or cryo-section
staining. Briefly, axolotl embryos were placed in 12-well-plates with 0.1% DMSO
(control) or 10μM Wnt-C59. At 24 hours post-treatment, embryos were injected
peritoneally with 1ul of 8μM EdU. At 72 hours post-treatment, embryos were
anesthetized with 0.02% benzocaine and fixed in 4% paraformaldehyde overnight.
The samples were dehydrated and rehydrated using a methanol series (0, 25, 50, 75,
and 100% in PBS). The samples were washed 3x with PBS with 1% Triton for 5
minutes, then bathed in 2.5% trypsin for 30 minutes, washed 3x with PBS with 1%
Triton for 5 minutes, and finally washed with ice-cold acetone for 10 minutes. ClickiT EdU reaction solution containing 1x Tris-buffered saline, 4mM CuSO4, FAM 488
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picolyl azide, and 100mM sodium ascorbate was used to visualize EdU incorporation
into the DNA of proliferating cells. DAPI was used to counter stain the samples. Cells
staining positive for EdU within 400μm of the tail tip were counted as well as cells
staining positive for DAPI within the same area. A proliferative index was calculated
as the ratio of EdU positive cells over DAPI positive cells. For cryo-section staining,
trypsinization and the ice-cold acetone wash were skipped. Results were analyzed in
GraphPad Prism software version 6.0 using one-way ANOVA.

5.3.5 Cell orientation and cell density measurements.
Cell orientation was measured using two-dimensional confocal imaging of fixed
tissue. The orientation of DAPI-stained nuclei of mesodermal cells was determined
relative to the forelimb bud epidermis. This was quantified as an angle by drawing a
line through the longitudinal axis of each nucleus and relating this line to a line drawn
parallel to the forelimb bud epidermis. There are several caveats of this approach for
determining cell orientation, and thus the results should be considered as preliminary
pending in vivo imaging using intracellular landmarks to determine the polarity of
cells and transgenes that reveal cell membranes (Wyngaarden et al. 2010). Cells with
nuclear angles were arbitrarily binned into 0-30, 30-60, or 60 to 90 degrees categories,
for DMSO treated and Wnt-C59 treated embryos. Three progress zones were also
arbitrarily defined to delineate proximal, middle, and distal regions of the forelimb
bud. Cell numbers per 2500 µm2 were counted in each progress zone. Results were
analyzed in GraphPad Prism software version 6.0 using one-way ANOVA.

89

5.4 Results
5.4.1 Wnt signaling is required around developmental stage 40 for axolotl forelimb
bud development.
The axolotl tail amputation assay was previously performed during the time that
embryos initiate forelimb development from developmental stage 40 to stage 44. I
anecdotally observed that Wnt-C59 treatment inhibited forelimb bud outgrowth. I
confirmed these observations by treating developmental stage 40 embryos with WntC59 or DMSO as controls, with eight embryos in each group. At stage 51, all eight
control embryos presented limbs that were in the process of digit formation. A deep
interdigital notch was observed between digits II and III, and a small indentation
separated digits I and II. In comparison, Wnt-C59 embryos did not form forelimbs;
representative images are shown in Figure 5.2 A and B. To determine if there is a
critical window within which Wnt-C59 blocks forelimb development, I varied the
time of dosing (Figure 5.1). Developmental stage 40 embryos that were treated with
Wnt-C59 for the first three days of the experiment did not form forelimbs; this
treatment also decreased the size of hindlimbs (Figure 5.2). All other treatment groups
had well-developed forelimbs and hindlimbs. These results show that Wnt signaling is
required at developmental stage 40 for axolotl forelimb development.
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Figure 5.1. Wnt signaling is required at developmental stage 40 for axolotl forelimb
development. A total of 155 embryos at stage 40 were used. Each group had five
animals. There were 30 treatment groups, and each of these groups was treated with
10μM Wnt-C59 for three days with an overlapping series of treatments throughout the
time course of forelimb development. There was one control group treated with 0.1%
DMSO at day 1 to day 3. Only a narrow window from day 1 to day three was
associated with Wnt-C59 inhibition of forelimb development.

5.4.2 Long-term phenotype of the Wnt-C59 treated animals
I treated developmental stage 40 embryos with 0.1% DMSO or Wnt-C59 for three
days and then reared the embryos to 1 year of age (Figure 5.2 C). Hindlimbs of
embryos with continuous Wnt-C59 treatment from Day1-3 were significantly smaller
and shorter than those of the controls (Figure 5.2 C-E, n=6, p < 0.01). These results
show that Wnt-C59 prevents forelimb development and decreases the size of
hindlimbs.
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Figure 5.2. Wnt-C59 prevents forelimb bud development and decreases hindlimb size.
White stippled lines outlined forelimbs. A) A DMSO treated embryo at
developmental stage 51. B) Embryos treated with Wnt-C59 for the first three days did
not form forelimbs. C) One-year-old adult axolotls treated with DMSO or Wnt-C59 as
embryos. Left: The DMSO control animal had fully developed forelimbs and
hindlimbs. Right: The Wnt-C59 treated animal had no forelimb, and smaller and
shorter hindlimbs compared to DMSO controls. D) Wnt-C59 decreased hindlimb
length. E) Wnt-C59 decreased the diameter of the hind limb at thigh level. *: p < 0.01
for contrasts of DMSO control vs Wnt-C59.

5.4.3 Down-regulation of Wnt3a expression by Wnt-C59 treatment is associated with
inhibition of forelimb bud development.
Limb bud outgrowth depends on signals emanating from the AER. Wnt3a is the
earliest known AER marker during chick limb development. It signals through the
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canonical β-Catenin pathway and mediates Fgf10 to induce Fgf8 expression in the
limb ectoderm during AER formation (Kengaku et al. 1998; Kawakami et al. 2001).
To investigate canonical Wnt signaling during axolotl forelimb bud development, I
performed Wnt3a immunostaining using embryos that were treated with either DMSO
or Wnt-C59. Embryos were treated for 72 hours after reaching developmental stage
40 (the samples were collected at 72 hours after the treatment). There was no apparent
AER observed during axolotl forelimb outgrowth. Wnt3a expression was higher in
DMSO vs. Wnt-C59 treated embryos in the epidermis on D-V/P-D sections of the
forelimb buds (Figure 5.3, p < 0.01, n = 6). Wnt3a did not appear to be differentially
expressed among mesodermal cells of DMSO and Wnt-C59 treated forelimb bud,
which suggests that the expression difference was specific to the epidermis.
Assuming that the epidermis is 1-2 cells thick, Wnt3a expression was significantly
higher on the apical side of epidermal cells in DMSO treated embryos (Figure 5.3, p <
0.01, n = 6), and Wnt-C59 treatment significantly decreased Wnt3a expression
(Figure 5.3, p > 0.01, n = 6). These data suggest that down regulation of Wnt3a
expression by Wnt-C59 treatment is associated with inhibition of forelimb bud
development.
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Figure 5.3 Down-regulation of Wnt3a expression by Wnt-C59 treatment is associated
with inhibition of forelimb bud development. All the samples were collected at 72
hours after DMSO or Wnt-C59 treatment. The white stippled lines outlined forelimb
buds. A-A’’) DMSO control forelimb bud stained for Wnt3a in red. Nuclei DNA was
labeled by DAPI in blue. B-B’’) Forelimb treated with Wnt-C59 and stained for
Wnt3a. C) Graph comparing Wnt3a expression between apical and basal sides of
DMSO or Wnt-C59 treated forelimb buds, and Wnt3a expression between DMSO or
Wnt-C59 treated forelimb buds at apical or basal sides of epidermal cells. *: p < 0.05
for the contrast of basal vs apical side of the epidermis in DMSO controls, and DMSO
control vs. Wnt-C59 for apical Wnt3a expression. Apical: Apical side of the
epidermis. Basal: Basal side of the epidermis.
94

5.4.4 Polarity of mesodermal cells is disrupted by Wnt-C59 treatment.
The early limb bud is described as an ectodermal bag of randomly arranged and
uniformly distributed mesodermal cells (Lu et al. 2008). The elongation of the limb
bud along the P-D axis is associated with polarized cellular behaviors (Gao and Yang
2013). The Wnt/PCP pathway regulates oriented cell behaviors, which is very
important for directional morphogenesis in developing limbs (Gao and Yang 2013).
Zo1 expression is associated with planar cell polarity and is a component of tight
junctions (Matter and Balda 2003). To determine if Wnt signaling affects the
expression of Zo1, I compared Zo1 expression between DMSO and Wnt-C59 treated
embryos. As was observed for Wnt3a, Zo1 expression was higher in apical epidermal
regions of DMSO treated embryos, and Zo1 expression was significantly higher in
DMSO vs. Wnt-C59 treated embryos (Figure 5.4 A-C, p < 0.01, n = 6). The
orientation of mesodermal cell nuclei underlying the epidermis appeared to differ
between DMSO and Wnt-C59 treated forelimb buds. The orientation of most
mesodermal nuclei (relative to the epidermal plane) in DMOS treated embryos was
greater than 60 degrees, while most of the nuclei in Wnt-C59 treated embryos were
less than 30 degrees (Figure 5.4 A-D, p < 0.01, n = 9). Nuclei close to the epidermis
of the forelimb bud were elongated and aligned to the epidermis perpendicularly in
DMSO treated embryos. Nuclei, located in the center of the limb bud, showed no
evidence of elongation and orientation. Mesodermal nuclei density was significantly
higher in progress zone 3 compared with progress zones 1 and 2 in DMSO treated
embryos (Figure 5.4 E, p < 0.01, n = 3). The density of nuclei differed significantly
among all three progress zones in Wnt-C59 treated embryos (Figure 5.4 E, p > 0.01, n
= 3). These results suggest that disruption of Wnt signaling by Wnt-C59 affects cell
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orientation and density, and this is associated with a decrease in Zo1 expression in the
epidermis.

Figure 5.4 Planar cell polarity of forelimb mesodermal cells is disrupted by Wnt-C59.
White stippled lines outlined forelimb buds. Cell counts and measures of cell
orientation are based on the qualification of DAPI-stained nuclei. A-A’) DMSO
control forelimb stained with Zo1. Nuclear DNA was labeled with DAPI. B-B’)
Forelimb treated with Wnt-C59 and Stained with Zo1. C) Zo1 expression in the apical
side of the epidermis of forelimb bud. D) Wnt-C59 disrupted the orientation of
96

mesodermal cell nuclei underlying the epidermis. E) Wnt-C59 altered cell density
gradients at the P-D axis. p > 0.01). *: p < 0.05 for the contrast of basal vs. apical side
in DMSO controls, or DMSO control vs. Wnt-C59 for apical Zo1 expression. α and β:
representative angles between the longitudinal axis of mesodermal cell nuclei and a
parallel line of drawn along the epidermal surface of the forelimb bud in DMSO or
Wnt-C59 treated embryos. 1, 2, and 3: progress zone 1, 2, and 3. Blue arrows:
representative mesodermal cell nuclei with angles more than 60° in DMSO treated
embryos, and angles less than 30° in Wnt-C59 treated embryos.

5.4.5 Wnt and Fgf signaling pathways promote cell progression at M-phase during
forelimb bud outgrowth.
Reiter and Solursh (1982) showed that the apical epidermis promotes mitosis of cellcultured, chick wing mesodermal cells. However, Pengfei Lu et al. (2008) showed
that Wnt/β-Catenin signaling promotes survival of AER cells in the mouse limb, but it
does not affect cell proliferation and survival of distal mesodermal cells. To determine
if Wnt and Fgf signaling pathways affect cell mitosis during axolotl forelimb bud
outgrowth, I stained forelimb tissues for a mitotic marker, phosphorylated histone H3.
In DMSO control embryos, many mitotic cells were observed (Figure 5.5 A); the
mitotic index of DMSO treated embryos was 18.2 ± 2.0% (Figure 5.5 C). Wnt-C59
treatment reduced the mitotic index (9.2 ± 1.0%) significantly (Figure 5.5 A-C, p <
0.01, n = 3). To take a closer look at mesodermal cells underlying the apical
ectoderm, I performed phosphorylated histone H3 staining using cryo-sections across
the forelimb bud at an A-P/P-D plane (Figure 5.5 G and H). The mitotic index in
DMSO treated embryos was 5.0 ± 0.9%. Wnt-C59 treated embryos showed a reduced
mitotic index 1.1 ± 0.5% (p < 0.01, n = 3). There were too few H3 positive cells to
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determine if there was a proximal-distal mitotic gradient. H & E staining also showed
that Wnt-C59 treatment decreased cell density in the forelimb bud (Figure 5.5 D-F, p
< 0.01, n = 3).

To further clarify that M-phase cell cycle progression of forelimb mesodermal cells is
required for forelimb bud outgrowth, I treated embryos with an Fgf signaling pathway
inhibitor because Fgf signaling is required for limb bud outgrowth (REF?). BGJ398
decreased the mitotic index (11.1 ± 1.3%) relative to DMSO controls (18.2 ± 2.0%)
(Figure 5.6 A-C, p < 0.01, n = 3). I also tested aurora kinase inhibitors that are known
to regulate mitotic events (Marumoto et al. 2003). Three aurora kinase inhibitors,
CYC116, MK-5108, and Danusertib, significantly inhibited forelimb bud outgrowth
(Figure 5.7, p < 0.01, n = 4). These results show that Wnt signaling is required for
mesodermal cell mitosis during axolotl forelimb bud outgrowth.
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Figure 5.5. Wnt signaling supports the mitosis of forelimb mesodermal cells. A-B)
DMSO control or Wnt-C59 treated forelimb field stained with phosphorylated
Histone H3 using whole-mount samples. Mitotic cells were stained in red. Total DNA
was stained with DAPI in blue. The white stippled line outlines the area within which
Histone H3 positive or DAPI stained cells were counted to determine the mitotic
index. C) Wnt-C59 treatment reduced the mitotic index of mesodermal cells of the
forelimb. D-E) H&E staining of the right forelimb of DMSO or Wnt-C59 treated
embryos. F) Wnt-C59 reduced mesodermal cell density in the forelimb buds. G-H)
DMSO control or Wnt-C59 treated forelimb field stained with phosphorylated
Histone H3 using cryo-sections. I) Wnt-C59 treatment reduced the mitotic index of
mesodermal cells in the forelimb. *: p < 0.05 for contrast DMSO control vs WntC59.
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Figure 5.6 Fgf signaling supports the mitosis of forelimb mesodermal cells. A-B)
Whole-mount phosphorylated Histone H3 staining for presumptive forelimb fields of
DMSO or BGJ398 treated embryos. The images show mitotic cells stained in red. The
total DNA was stained with DAPI in blue. The white stippled line areas were used to
count phosphorylated Histone H3 positive or DAPI stained cells. C) BGJ398
treatment reduced the mitosis index of the forelimb. *: p < 0.05 for contrast DMSO
control vs BGJ398.

Figure 5.7 Aurora Kinase inhibitors inhibit forelimb bud outgrowth. The black
stippled line outlines forelimbs of the embryos. A-D) Representative images showing
embryos treated with DMSO, CYC116, MK-5108, and Danusertib. D) CYC116, MK5108, and Danusertib significantly halted forelimb bud outgrowth. *: p < 0.01 for
contrasts DMSO control vs CYC116, MK-5108, or Danusertib.
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5.4.6 Wnt signaling is critical for mesodermal cell proliferation in the forelimb bud.
Cell proliferation is precisely controlled during embryonic development. Vertebrate
limb bud morphogenesis depends upon regulated cell proliferation. A prominent
hypothesis, the “proliferation gradient” model along the P-D axis, was proposed to
explain how proliferation gradients engender limb bud outgrowth (Ede and Law
1969). To test whether there is a proliferation gradient, and whether Wnt signaling
plays a role in cell proliferation during forelimb bud outgrowth, cell proliferation was
assayed at 72 hours post developmental stage 40 using EdU staining. To label
proliferating cells, I delivered EdU at 48 hours post developmental stage 40. Wnt-C59
treatment significantly reduced the cell proliferation index of forelimb bud
mesodermal cells; the proliferation index was 52.8 ± 6.2% compared to 68.3 ± 3.8%)
for the DMSO control (Figure 5.8 A, A’, B, B’, and D, p < 0.01, n = 6). However, cell
proliferation did not differ between proximal and distal mesodermal cell populations.
Thus, there does not appear to be a P-D proliferation gradient at this stage of axolotl
limb bud development. Fgf signaling inhibitor BGJ398 also significantly decreased
the cell proliferation index (BGJ398 vs DMSO control: 48.2 ± 12.2% vs 67.9 ± 3.8%,
p < 0.01, n = 4) (Figure 5.8 A, A’, C, C’ and E). The proliferation index of Wnt-C59
treated samples was lower than that of BGJ398 treated samples, but the difference
was not statistically significant (p > 0.05, n = 4). These results show that Wnt
signaling regulates mesodermal cell proliferation.
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Figure 5.8 Wnt and Fgf signaling pathways regulate cell proliferation of mesodermal
cells of the forelimb bud. EdU was injected 48 hours after treatment, and samples
were collected 72 hours after treatment. Cryo-sections of D-V/P-D planes at forelimb
bud levels were used for EdU staining. A) DMSO control forelimb bud stained with
EdU. Proliferating cells were detected by EdU in green. Cell nuclei were labeled with
DAPI in blue. A’) Detail image of A. B) Forelimb treated with Wnt-C59 and stained
with EdU. B’) Detail image of B. C) Forelimb treated with BGJ-398 and stained with
EdU. C’) Detail image of C. D) Wnt-C59 reduced the cell proliferation index relative
to the DMSO control. E) BGJ398 reduced the cell proliferation index relative to the
DMSO control. *: p < 0.05 for contrasts DMSO control vs Wnt-C59 or BGJ398.

5.5 Discussion
In this chapter, I demonstrated the requirement of Wnt signaling pathways during
forelimb bud outgrowth. Wnt and Fgf signaling pathways regulated cell proliferation
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and mitosis of mesodermal cells during axolotl early forelimb bud outgrowth.
Blocking the Wnt and Fgf signaling pathways reduced cell proliferation and mitosis
of mesodermal cells, which are required for forelimb bud outgrowth. My results also
suggest that cell orientation and cell density of forelimb bud mesodermal cells was
disrupted by Wnt-C59 treatment. These differences between Wnt-C59 and control
forelimb buds may trace to a disruption of Wnt-mediated patterning during forelimb
bud outgrowth.

Wnt3a expression altered by Wnt-C59 is associated with inhibition of forelimb
bud outgrowth.
Wnt3a is an early marker for the AER in chick (Kengaku et al. 1998; Kawakami et al.
2001). Although I did not observe AER formation during axolotl forelimb outgrowth,
I did observe that Wnt3a was highly expressed in the epidermis of a normally
developing forelimb bud. Wnt-C59 altered Wnt3a expression and this was associated
with inhibition of forelimb bud development. These results are consistent with ten
Berge et al. (2008), who showed that Wnt3a cooperates with Fgf8 to maintain
mesodermal cells in an undifferentiated, proliferative state to promote outgrowth of
chick limb buds. This is the first study to suggest a role for Wnt3a in axolotl forelimb
bud outgrowth.

Reduced cell proliferation and mitosis by Wnt-C59 is associated with inhibition
of forelimb bud outgrowth.
Limb bud outgrowth relies on a continuous ectodermal-mesodermal interaction.
Epidermal cells are necessary for controlling proliferation and mitosis (Lu et al.
2008), and failure of communication between the ectoderm and mesoderm disrupts
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limb development (Fernandez-Teran, Ros, and Mariani 2013). In this study, I found
that about 5 percent of cells were mitotic in the forelimb bud in DMSO treated
controls. Wnt and Fgf pathway inhibitors significantly reduced cell proliferation and
mitosis of mesodermal cells. Ten Berge et al. (2008) reported that Wnt3a alone
promotes the growth of chick limb mesenchyme in culture, while Fgf8 alone does not.
However, Fgf8 synergistically enhances the proliferative effect of Wnt3a. It would be
interesting to titer Fgf and Wnt signaling activities by varying the dosage of chemical
inhibitors to determine if these pathways synergistically regulate cell proliferation and
mitosis during limb development. It would also be interesting to investigate the aurora
kinase inhibitors that were shown to inhibit limb regeneration in this study, as this
might link Wnt signaling to a specific mitotic mechanism.

The critical window for forelimb bud outgrowth
I identified a narrow window around developmental stage 40 within which Wnt-C59
blocked forelimb bud outgrowth. This suggests that the requirement for Wnt signaling
during limb development has a distinct, offset timing. It seems reasonable to assume
that the offset requirement for Wnt signaling coincides with systemic changes in
signaling centers that regulate limb bud outgrowth. For example, a regulatory loop
consisting of Wnt factors (Wnt3a, Wnt2b, and Wnt8c) and fibroblast growth factors
(Fgf8 and Fgf10) regulates AER formation and limb bud outgrowth (Kawakami et al.
2001). Wnt7a expression in non-AER limb ectoderm determines dorsal limb cell
identity and dorsal-ventral axis regulation (Riddle et al. 1995). Wnt signaling around
developmental stage 40 may coincide with these signaling mechanisms.
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Applications for using the axolotl embryo model to identify chemicals that alter
limb development and regeneration
The discovery that Wnt-C59 inhibits limb development was serendipitous as it was
discovered in a chemical genetic screen using a tail regeneration assay (Ponamareva
et al 2015). Many chemicals discovered from this screening project provides tools for
investigating mechanisms of tail regeneration (Voss et al 2019). The discovery of
Wnt-C59 as an inhibitor of limb development suggests that this same axolotl
screening platform can be used to identify chemicals for studies of limb development
and regeneration. Additionally, the axolotl embryo assay could provide an efficient
and cost-effective tool for screening chemical libraries for toxicity and limb
developmental defects.
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CHAPTER 6: SUMMARY AND DISCUSSION: SIGNALING PATHWAYS
DURING AXOLOTL TAIL REGENERATION AND FORELIMB BUD
OUTGROWTH

Signaling pathways and axolotl tail regeneration
Signaling pathways are activated by injury-induced cytokines, growth factors, and
local activators during regeneration. The axolotl tail regeneration model provides an
excellent tool to investigate signaling pathways during tissue regeneration. The
axolotl embryo is capable of regenerating an amputated tail in about seven days.
Using this model, Ponomareva et al. (2015) identified three chemicals inhibitors
(SB505124, Wnt-C59, and BGJ398) of Tgf-β, Wnt, and Fgf signaling pathways that
blocked axolotl tail regeneration. The purpose of my dissertation was to study these
chemical inhibitors in more depth as the results might guide progress in understanding
mechanisms of regeneration, and ultimately cellular reprogramming and tissue
engineering toward repairing complex body parts in mammals.

Disruption of major signaling pathways reduces cell mitosis and cell
proliferation.
In my model, axolotl tail regeneration initiates after amputation of 2mm of the distal
tail tip. The amputation injury is thought to induce typical innate immune responses,
including clotting, immune cell activation, and cell death. Within 1 hour, a simplified
epithelium forms over the exposed tail stump. Underneath the epidermis, progenitor
cells from different tissues organize in the tail tip and form a regenerating bud. In
chapter 2, 3 and 4, I showed that inhibition of Tgf-β, Wnt, or Fgf signaling pathways
by SB505124, Wnt-C59, or BGJ398 yielded decreased cell proliferation and mitosis
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in several tissue types including spinal cord, dorsal fin, ventral fin, and distal tail tip
(Table 6.1). However, the Fgf signaling pathway inhibitor BGJ398 did not
significantly affect cell proliferation in the spinal cord. Upon Fgf inhibitor release, the
tail regeneration process re-initiated and went to completion. It is thought that Fgfs
are morphogens that support progenitor cell proliferation. My results show that signal
pathway inhibition can affect tissues differently and a cell proliferation response is not
sufficient for regeneration. For example, Naringenin inhibited tail regeneration but not
the cell proliferation response (Table 6.1). It seems likely that signaling pathways
synergistically and cooperatively control cell proliferation during axolotl tail
regeneration. In the future, it will be important to test for synergistic and cooperative
effects of inhibitors to determine how pathways interact to regulate cell proliferation
and mitosis.

Table 6.1 Inhibitors of cell proliferation and mitosis.
Target

Signaling

Cell mitosis

pathway

Cell
proliferation

SB505124

Alk4/5/7

Tgf-β

↓

↓

Naringenin

p-Smad3

Tgf-β

-

NS

Wnt-C59

Porcupine

Wnt

↓

↓

BGJ398

Fgfr1/2/3

Fgf

↓

↓ but not the
spinal cord

✓: Expressed; ↑: Increased; ↓: Decreased; NS: Non-significant; -: Not done.
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Ligands may induce transcriptional changes that jointly regulate Tgf-β, Wnt,
and Fgf signaling.
I found that Tgf-β1 was up-regulated during axolotl tail regeneration. Upregulation of
Tgf-β1 was similarly found during tadpole tail regeneration (Denis et al. 2016;
Levesque et al. 2007). In my studies, I used Tgf-β pathway inhibitor SB505124,
which inhibits Alk5, Alk4, and Alk7 type I receptors. It seems plausible that Tgf-β1
acts through one or more of these receptors to orchestrate axolotl tail regeneration.
However, other Tgf-β pathway ligands could be important. For example, Inhbb
transcripts were decreased at 24hpa upon Wnt pathway inhibition (Ponomareva et al.
2015). Inhbb shares a β subunit with Activin, and its function is thought to oppose
Activin (Zhu et al. 2012; Namwanje and Brown 2016).

In contrast to increasing Tgf-β1 levels during regeneration, Wnt3a was decreased at
24 and 72hpa in the regenerating tail. While this suggests down-regulation of some
Wnt pathway activities, other Wnt ligands (that were not quantified in my study) may
activate Wnt signaling during tail regeneration. For example, Wnt-C59 treatment
caused a significant decrease in Wnt5a transcription at 24, 48, 72, and 120hpa,
suggesting a requirement for Wnt5a during later stages of regeneration, when the rate
of tissue outgrowth increases (Ponomareva et al. 2015). Additionally, Wnt-C59
treatment significantly decreased Fgf9 transcription at 24hpa, and then later between
72-120hpa (Ponomareva et al. 2015). As discussed above, Inhbb may function to
oppose Activin and upregulate Tgf-β signaling. Tgf-β signaling appears to act
upstream of Wnt signaling, which in turn up-regulates and positively feeds back on
Tgf-β signaling. In future studies, it will be essential to investigate the crucial roles of
Wnt5a during axolotl tail regeneration by creating an axolotl Wnt5a knock-out
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predicted to show decreased expression of Fgf9 and Inhbb at 24 hpa, and inhibited
regeneration. This would potentially identify a transcriptional network that jointly
regulates Tgf-β, Wnt, and Fgf signaling pathways (Figure 6.1).

Inhibin

wnt5a

fgf9

Figure 6.1 Crucial ligands regulate Tgf-β, Wnt, and Fgf signaling pathways.
SB505124 and Naringenin differentially affect early Smad mediated TGF-β
signaling.
In chapter 2, I showed that chemical disruption of Tgf-β signaling altered Smad
mediated Tgf-β signaling pathway components. In regenerating tails, both Smad2 and
Smad3 were activated upon tail amputation as early as 1hpa. p-Smad2 steadily
increased afterward at the tested time points while p-Smad3 decreased. Application of
SB505124 down-regulated both p-Smad2 and p-Smad3 at all post-amputation time
points and blocked tail regeneration. Naringenin also down-regulated p-Smad2 at all
post-amputation time points, delayed peak p-Smad3 expression, and completely
blocked tail regeneration. However, SB505124 treatment affected p-Smad2 at an
earlier time and to a greater degree than p-Smad3, while Naringenin affected p-Smad3
at an earlier time and to a greater degree than p-Smad2 (Table 6.2). The opposing
roles played by Smad2 and Smad3 have been studied during both embryo
development and tissue regeneration. The differential regulation of p-Smad2 and pSmad2 may lead to differences in progenitor cell proliferation and mitosis. Further
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studies are needed to understand the different requirements for Smad2 and Smad3
signaling and their role in regulating cell proliferation and mitosis during axolotl limb
and tail regeneration.

Table 6.2 SB505124 and Naringenin differentially affect Smad-mediated TGF-β
signaling.
DMSO

SB505124 vs

Naringenin vs

DMSO

DMSO

p-Smad2 at 0hpa

✓

p-Smad2 at 1hpa

↑

↓↓↓

↓

p-Smad2 at 6hpa

↑

↓

↓

p-Smad2 at 12hpa

↑

↓

↓

P-Smad3 at 0hpa

✓

p-Smad3 at 1hpa

↑

NS

↓↓↓

p-Smad3 at 6hpa

↓

↓

↑

p-Smad3 at 12hpa

↓

↓

NS

✓: Expressed; ↑: Increased; ↓: Decreased; ↓↓↓: Decreased more than the other
chemical; NS: Non-significant.

Inhibition of Tgf-β, Wnt, or Fgf signaling pathways alters phosphorylation of
Erk and Akt.
I found that p-Erk and p-Akt responded to tail amputation at an early phase of tail
regeneration. P-Erk was expressed at the time of tail amputation, increased at 1hpa
and then decreased at 6hpa. P-Akt was expressed at the time of tail amputation; it
changed very little at 1hpa and decreased at 6hpa. Overall, increased expression of p110

Erk and decreased expression of p-Akt appear to be important early signaling
responses. Furthermore, p-Erk and p-Akt were significantly up-regulated in
SB505124-treated tails, but significantly down-regulated in Naringenin-treated tails at
1hpa; thus, p-Erk and p-Akt were affected by disruptions of Tgf-β signaling (Table
6.3). Moreover, Wnt and Fgf signaling pathways regulated phosphorylation of Erk
and Akt. In chapter 3, I found that disruption Wnt signaling pathway by Wnt-C59
increased phosphorylation of Erk at 48hpa and phosphorylation of Akt at 48 and
72hpa. In chapter 4, I found that disruption of Fgf signaling by BGJ398 downregulated p-Erk and p-Akt. Overall, all three signaling pathways affected the
phosphorylation of Erk and Akt; pathways are known to regulate cell proliferation,
cell survival, and cell fate specification (Table 6.4). Future studies are needed to
determine if changes in Erk and Akt phosphorylation affect cell proliferation and
mitosis, as well as the regenerative outcome in axolotl embryo model.
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Table 6.3 SB505124 and Naringenin differentially affect non-Smad mediated TGF-β
signaling.
DMSO SB505124 vs
DMSO

Naringenin vs
DMSO

p-Erk at 0hpa

✓

p-Erk at 1hpa

↑

↑

↓

p-Erk at 6hpa

↑

↑

NS

p-Erk at 12hpa

↑

↓

NS

p-Akt at 0hpa

✓

p-Akt at 1hpa

NS

↑

↓

p-Akt at 6hpa

↓

NS

↓

p-Akt at 12hpa

↓

NS

↓

✓: Expressed; ↑: Increased; ↓: Decreased; NS: Non-significant.
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Table 6.4 Effects of Wnt-C59 and BGJ398 on Erk and Akt signaling.
DMSO

Wnt-C59 vs DMSO

BGJ398 vs
DMSO

p-Erk at 0hpa

✓

p-Erk at 24hpa

NS

NS

NS

p-Erk at 48hpa

↓

↑

↓

p-Erk at 72hpa

↑

NS

NS

p-Akt at 0hpa

✓

p-Akt at 24hpa

↓

NS

NS

p-Akt at 48hpa

NS

↑

↑

p-Akt at 72hpa

NS

↑

↑

✓: Expressed; ↑: Increased; ↓: Decreased; NS: Non-significant.

Inhibition of Wnt or Fgf signaling pathways affects Wnt/β-Catenin signaling.
In chapter 3, I found that β-Catenin was decreased at 48hpa and increased at 72hpa
relative to 0hpa during axolotl tail regeneration. Wnt-C59 treatment increased βCatenin at 48hpa. In chapter 4, I found that BGJ398 treatment increased Wnt3a
expression at 48hpa and 72hpa; it also increased β-Catenin at 48hpa (Table 6.5).
These data suggest that some Fgf signaling activities are inversely correlated with
Wnt/β-Catenin signaling.

113

Table 6.5 Effects of Wnt-C59 and BGJ398 on Wnt3a and β-Catenin expression.
DMSO

Wnt-C59 vs.
DMSO

BGJ398 vs.
DMSO

Wnt3a at 0hpa

✓

Wnt3a at 24hpa

↓

NS

Wnt3a at 48hpa

NS

↑

Wnt3a at 72hpa

↓

↑

β-Catenin at 0hpa

✓

β-Catenin at

NS

NS

NS

↓

↑

↑

↑

NS

NS

24hpa
β-Catenin at
48hpa
β-Catenin at
72hpa
✓: Expressed; ↑: Increased; ↓: Decreased; NS: Non-significant.
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Figure 6.2 Preliminary network for Tgf-β, Wnt, and Fgf signaling pathways during
axolotl tail regeneration. Red arrows show how chemicals increased expression of
signaling components. Blue arrows show how chemicals decreased expression of
signaling components. The numbers report the earliest times (hours post amputation hpa) at which signaling components were affected.

Wnt3a is an essential ligand for forelimb bud outgrowth.
Wnt3a is known to mediate canonical Wnt/β-Catenin signaling and is an early marker
of the AER in amniote vertebrate limbs (Kengaku et al. 1998; Kawakami et al. 2001).
In chapter 5, I detected Wnt3a expressed in the epidermis of the developing forelimb
bud. Wnt-C59 altered Wnt3a levels and expression patterns in the limb and prevented
forelimb bud outgrowth. To my knowledge, this is the first study analyzing Wnt3a
ligand in axolotl forelimb bud outgrowth. The Wnt3a expression pattern in the
epidermis during axolotl limb development maybe characteristic of non-amniote
vertebrate limb development. My results suggest a role for Wnt3a in forelimb bud
outgrowth in the axolotl but do not rule out essential roles for other Wnt ligands. For
example, Wnt2b-Wnt8c/β-Catenin signaling in the lateral plate mesoderm is vital for
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Fgf10 expression in the mesenchyme of the presumptive chick limb bud (Kawakami
et al. 2001). Also, Wnt5a regulates limb bud initiation by controlling asymmetric cell
behaviors (Gao and Yang 2013; Wyngaarden et al. 2010; Gros et al. 2010).

Planar cell polarity in epidermal cells and underlying mesodermal cells is
associated with proximal-distal axis elongation.
In chapter 5, I showed that Wnt signaling pathway inhibition altered the expression of
Wnt3a and Zo1 in epidermal cells, appeared to affect the polarity of mesenchymal
cells, and blocked forelimb bud outgrowth. The first definitive demonstration of PCP
during limb development was established by showing symmetrical localization of
Vangl2 in newly formed mesenchymal cells along the proximal-distal limb axis of
mice (Gao et al. 2011). In Wnt5a knockout mice, limb elongation is impaired (Gros et
al. 2010). Future studies are needed to rigorously document changes in cell polarity
that would establish Wnt/PCP signaling in the developing axolotl forelimb.

Wnt and Fgf signaling pathways regulate cell proliferation and mitosis of limb
mesodermal cells.
Continuous ectodermal-mesodermal interaction is important for limb bud outgrowth.
Epidermal cells of the limb bud are necessary for controlling cell proliferation and
mitosis during forelimb outgrowth (Lu et al. 2008). In Chapter 5, the developing
axolotl forelimb bud was shown to contain a high number of mitotic cells. Both WntC59 and BGJ398 reduced mesodermal cell proliferation and mitosis. Thus, Wnt and
Fgf signals are essential to maintain the function of the apical epidermis as an inducer
of cell proliferation and mitosis in underlying mesodermal cells. To further confirm
that cell mitosis is necessary for successful forelimb bud outgrowth, I showed that
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three different aurora kinase inhibitors CYC116, MK-5108 (VX-689), and Danusertib
halted forelimb bud outgrowth, to different degrees. Thus, the proper amount of cell
mitosis is required for forelimb bud outgrowth. It would be interesting to find a direct
link between Wnt signaling and aurora kinases during axolotl forelimb bud
outgrowth. Overall, Wnt and Fgf signaling pathways play essential roles in regulating
cell proliferation and mitosis to assure forelimb bud outgrowth.

The critical window for forelimb bud outgrowth
In Chapter 5, a critical narrow window around developmental stage 40 was found
during which Wnt-C59 completely blocked forelimb bud outgrowth, thus suggesting a
distinct, offset timing for Wnt signaling to regulate limb development. It appears that
the offset requirement for Wnt signaling coincides with more systemic changes in
signaling centers that regulate forelimb bud outgrowth. For example, a regulatory
loop consisting of Wnt factors and the fibroblast growth factors regulates AER
formation and limb bud outgrowth (Kawakami et al. 2001). Wnt7a expression in nonAER limb ectoderm determines dorsal limb cell identity and thus dorsal-ventral axis
regulation (Riddle et al. 1995). Wnt signaling around developmental stage 40 may
relate to systemic signaling changes in signaling centers that regulate forelimb bud
outgrowth.

In summary, this dissertation examined the requirements of Tgf-β, Wnt, and Fgf
signaling pathways during axolotl tail regeneration and the requirement of Wnt
signaling during axolotl forelimb bud outgrowth. Tgf-β, Wnt, and Fgf signaling
pathways are required during axolotl tail regeneration. Inhibition of all three pathways
affects Erk and Akt signaling pathways, and cell proliferation and mitosis. The Wnt
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signaling pathway is required for forelimb bud outgrowth, and failure to develop
forelimbs is associated with altered Wnt3a and Zo1 expression and decreased cell
proliferation and mitosis. These data enrich understanding of signaling pathway
network dynamics that underlie tissue regeneration and vertebrate limb development.
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